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ABSTRACT 
Relative Quantitation of Peptides by Inductively Coupled Plasma Mass 
Spectrometry 
Pritesh Patel 
Currently, the detectlon/quantltation of biomolecules using Inductively Coupled 
Plasma Mass Spectrometry (ICR-MS) is focused on heteroatom containing (e.g. S. 
P, Se, Cu) compounds. This limits the scope of ICP-MS as a routine analytical tool 
in the bioanalytical sciences. To increase this scope novel strategies to 
incorporate elemental labels have been developed. Chemical derivatisation is one 
such strategy. Cyclic diethylenetriaminepentaacetic acid anhydride (cDTPA), a 
bifunctional chelating agent (BFCA), is reacted with N-terminal amines and is 
subsequently chelated with trivalent metals. This allows the detection of peptides 
that contained no heteroatom using liquid chromatography (LC)-ICP-MS. The 
derivatisation efficiency, optimised using LC-UV/vis detection, is approximately 
99%. The derivatisation and chelation reactions products are characterised using 
LC-electrospray ionisation tandem mass spectrometry (ESI-MS-MS). 
The labelling procedure allowed the relative quantitation of peptides, by differential 
isotopic labelling. Two individually derivatised peptide samples are chelated with 
natural isotopic abundance and isotopically enriched ^^^Eu respectively. The Eu 
labelled peptides were combined and analysed by LC-ICP-MS. The resulting 
^"EU:^^^EU ratio, measured using the pseudo steady state approach for transient 
signals; is then used to calculate the original peptide proportions using a modified 
isotope dilution equation. The ICP-MS measured peptide ratio was within 2.8% of 
the theoretical peptide ratio. The absolute detection limit for the relative 
quantitation of Eu labelled bradykinin was 5 pmol, which is comparable to current 
ESI-MS methods. When cDTPA derivatisation was applied to a complex sample 
multiple by-products were observed in the LC-UV/vis chromatogram. However, the 
corresponding LC-ICP-MS chromatogram suggested that only singly derivatised 
peptides were chelated with the metal. 
To overcome by-product formation monoreactive BFCAs, namely isothiocyanate-
benzyl-EDTA (SCN-Bz-EDTA) and isothiocyanate-benzyl-DTPA (SCN-Bz-DTPA). 
were evaluated as derivatisation reagents. Solid phase analytical derivatisation 
(SPAD) and solid phase extraction (SPE) were also evaluated for speed and ease 
of use. The monoreactive nature of SCN-Bz-EDTA and SCN-Bz-DTPA gave singly 
derivatised peptides when applied to complex samples. However, the resulting 
derivatisation efficiency was low and no significant improvement in efficiency was 
noted when SPAD was used. SCN-Bz-EDTA derivatised peptides could not be 
chelated to trivalent metals, whilst chelation occurred with SCN-Bz-DTPA 
derivatised peptides. Eu labelled peptides were isolated and selectively extracted 
by SPE for relative quantitation by LC-ICP-MS. However, due to the instability of 
the isothiocyanate reagent and instrumental effects the relative error on the 
measured peptide ratio was greater than 45% when compared to the theoretical 
ratio. Although the peptide ratio obtained using the SPE method agreed with the 
ratio from the non extracted sample. 
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CHAPTER 1 INTRODUCTION 
Chapter 1 
PROTEOMICS 
The term proteomics^ was coined in the mid 1990's to describe the process of 
structural identification and cataloguing of the entire protein complement 
expressed by a specific genome at any given time. This was analogous to the term 
'genomics', which was used to describe mapping of the human genome that was 
being undertaken at the time. Since then, analysis of the proteome has rapidly 
grown in importance, becoming the leading discipline in life sciences, and which is 
also considered to be one of the greatest challenges in the post genomic era. 
Figure 1-1 illustrates the evolution of bio-molecular research over the past twenty 
years. 
Genes 
RNA 
Genomics 
Transcriptomics 
Peptides and Proteins Proteomics 
Metabolites Metabolomics 
Figure 1-1 Evolution of bio-molecular research from genomics to metabolomics through 
proteomics. 
Early proteomic research concentrated on the cataloguing of proteins and 
development of protein databases, with currently over 6000 scientific papers 
published in this field alone^. To date, proteomes of numerous prokaryotic and 
eukaryotic species have been characterised, resulting in extensive information on 
the proteomes of these organisms. Modern proteomic research has now focused 
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on the characterisation of the proteome of human cells, organelles, specific tissues 
and organs. 
Research into proteomics has highlighted the complexity of the proteome. For 
example, while there only 25,000 genes in the human genome, it is estimated that 
there can be up to 100.000 functionally unique proteins expressed across the 
assorted human cell types. Given that multiple modified forms of each protein 
exists, including variations in amino acid sequence at specific sites 
(polymorphism) and post-transitional modifications (e.g. phosphorylation), the 
number of proteins could approach one million^. 
Proteomics has been defined as the large scale analysis of the protein properties 
(expression levels, post-translational modifications, interactions etc.) of a cell or 
organism^. The aim is to obtain a global and integrated view of disease processes, 
environmental effects, cellular processes and networks at the protein level by 
studying all the proteins of a cell rather than each one individually. 
Several different sub-disciplines can be grouped under the term proteomics to 
describe specific areas of proteomic research such as, protein expression 
proteomics. funcfional proteomics, protein modification, protein interaction, 
structural proteomics and metallomics. Since the advent of the term proteomics, 
many other "omic" terms have been coined to describe various different areas of 
research in proteomics. Sub-disciplines such as interactomics (the study of 
interactions between proteins, RNA and DNA); ligandomics (the study of biological 
molecules and metals); functomics; separomics and many more. However, none 
of these "omics" refer to new areas of research that did not exist prior to coining of 
these new words'*. 
1.1 Proteomics Sub-Disciplines 
Figure 1-2 shows some of the important sub-disciplines associated with 
proteomics and their potential applications to biology. 
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Figure 1-2 Sub-disciplines of proteomics and applications to biology. Modified from Graves 
Functional proteomics is the study of specific proteins in order to gain information 
about protein signalling, disease mechanisms, or protein-drug interactions. 
Typically, selected proteins are isolated by either affinity chromatography or by 
using protein ligands. 
Structural proteomics attempts to identify all the proteins within a protein complex 
or organelle, determine their location and to characterise all protein-protein 
interactions, resulting in a cell map®. The information can help to elucidate the 
overall architecture of a cell and explain how certain proteins give a cell its unique 
characteristics^. 
Post translational modifications (PTMs) are of extreme biological importance. The 
presence or absence of a particular protein often determines if its designated 
biological function is carried out, however, this may not always be the case. It has 
been shown that PTM's can influence a number of cellular processes and an 
enormous number of proteins have been shown to be post-translationally 
regulated by a variety of different modifications. More than a hundred protein 
modifications are known and more will likely be discovered®. Proteins are known to 
be modified post-translationally in response to a variety of intracellular and 
extracellular signals. The effects of PTMs include change in enzymatic activity, 
interactions with other proteins, subcellular localisation, targeted degradation etc. 
Phosphorylation is probably the most widespread, biologically important of the 
post-translational modifications®, and has been found in nearly all cellular 
processes®. Reversible phosphorylation occurs at the Ser, Thr. Tyr residues on 
proteins and peptides where a phosphoryl group (-PO3) is attached or removed 
through protein kinases or phosphatase. The majority of methods published on the 
study of PTMs are based on profiling phosphorylation, whether to identify 
phosphorylated peptides or to determine the degree of phosphorylaytion^°. The 
analysis of phosphorylated peptides can be performed using many analytical 
techniques, hence the popularity of such methods as two-dimensional gel 
electrophoresis (2-DE), Edman degradation, molecular mass spectrometry and 
Inductively Coupled Plasma Mass Spectrometry (ICP-MS). 
1.1.1 Quantitative Methods 
A major goal of proteomic research is the quantitative analysis of all proteins 
expressed in a cell, tissue, or an organism at a specific moment and under certain 
conditions. Traditionally, quantitative proteome analysis was performed by the 
differential staining of 2-DE gels, however, the inherent disadvantages of using 2-
DE gels has prompted new approaches to quantitation. 
It was previously thought that the analysis of messenger ribonucleic acid (mRNA) 
expression would provide quantitative data on the proteome. However, 
experimental observation in studies comparing the amount of mRNA to protein 
levels showed there was no correlation^V In hindsight this was unsurprising 
because proteins catalyse all biological functions and the levels are determined by 
key effector molecules. In addition, proteins undergo activation and deactivation 
through post-translationat mechanisms which cannot be predicted by studying 
mRNA levels. 
Quantitative analysis using mass spectrometry has historically employed stable 
isotopes such as ^H. ^^C, ^^N, for the absolute quantitation of peptides. The 
method requires the addition of an internal standard which is chemically identical 
to the analyte of interest, apart from the isotopic enrichment. The absolute amount 
of the analyte is determined by comparison with a standard curve^^. The addition 
of an internal standard is a necessity for quantitation using techniques such as 
electrospray ionisation (ESI) mass spectrometry because of the variable ionisation 
efficiencies for analytes of different composition and from different elution times 
during chromatographic analysis. 
1.2 Expression Proteomics 
When exposed to different environmental, pathological, pharmacological or 
genetic perturbations, cells respond by altering protein abundances via 
transformations, or changes in protein structure by post-translational 
modification^^. Therefore, it is an essential part of proteomics to quantify these 
changes in protein abundance. Expression proteomics (relative quantitation) is the 
method of choice for comparing the differences in protein expression between 
samples that differ by some variable, such as between diseased and healthy cells. 
The approach compares the expression of either the entire proteome or sub-
proteome, and which can be used to identify novel proteins in signal transduction 
or disease specific proteins. For example, Mann and co-workers^'* relatively 
quantified the differences between epidermal growth factor (EGF)-stimulated and 
non-stimulated (EGF) cells, and identified 28 specifically enriched proteins which 
provided information on related biochemical pathway. 
In practice, relative quantitation of proteomic samples is based on the isotope 
dilution theory and is achieved when a protein mixture (reference sample) labelled 
with natural or light isotopes is compared to a second sample containing the same 
proteins at different abundances, but labelled with enriched or heavy isotopes. In 
theory, all the sample components will exist in peptide pairs after tryptic digestion 
with identical sequences, but differ in mass due to the isotope incorporation. The 
peptide pairs have the same physico-chemical properties so they are expected to 
behave in the same manner during sample isolation, separation and ionisation. 
Hence, the ratio of the isotopic Intensities of the spiked and unspiked samples Is 
related to the relative abundances of proteins in the original sample. 
The past few years have seen the development of several labelling strategies for 
the purposes of expression proteomics illustrated in Figure 1-3. These approaches 
have been used with ESI-MS to allow simultaneous quantitation and identification. 
Cell Growth 
Condition 1 Condition 2 
Extraction I 
Protein Extract 
I Tryptic Digest I 
Digested proteins 
\ / 
Mix of Heavy and Light peptides 
Metabolic labelling 
Isotope Coded Affinity Tag 
Labelling with ^^O water 
Peptide derivatisation 
Figure 1-3 Strategies for labelling proteomic samples with stable isotopes. 
Stable isotopes labels can be introduced into proteins at various stages of sample 
preparation before mass spectrometric analysis. However, the ideal stratagem Is 
that labelled (heavy and light) samples should be combined directly after the 
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labelling step. Since any variations caused by subsequent sample preparation 
would be equal and relative for the combined samples. 
1.2.1 Metabolic Isotope labelling 
A critical part of the isotope labelling process is the assurance of complete 
derivatisation (labelling) of all proteins within a sample. Metabolic labelling is the 
method of choice when it is required to cover the entire proteome, because the 
stable isotopes are introduced at the earliest possible time, during the processes 
of cellular metabolism (Figure 1-3). Hence, the two samples can be combined prior 
to protein extraction, thus any variations from subsequent sample preparation 
would be relative for the combined samples. The strategy of metabolic isotope 
labelling differs to that of the chemical isotope labelling method by targeting the 
entire protein/peptide sample rather than a specific amino acid residue (cysteine in 
the case of isotope coded affinity tags, and lysine in the case of mass coded 
affinity tags). Labelling through metabolic incorporation is one of the most accurate 
procedures for quantitation of proteins from a cell line because every peptide 
produced by the cell and cleaved by enzymatic digestion will have an isotopically 
identical internal standard. Several groups^^"^^ have developed metabolic labelling 
strategies that enable the stable isotope coding of all proteins within a sample. 
These strategies used various stable isotopes to label the internal standards such 
as ^H.'^C,'^N and '®0. 
1.2.1.1 '^N Labelling 
Oda a/.^^ described the first method of metabolic labelling, using yeast cells and 
growing them on a natural N and uniformly labelled ^^ N enriched media. At the end 
of the growing period the cell cultures were combined and separated by sodium 
dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) or reverse phase 
high performance liquid chromatography (LC) and were relatively quantified and 
identified using ESI-MS. The authors reported the relative quantitation of 42 high 
abundant proteins and were able to quantitate and identify in vivo phosphorylation 
sites^^. There was no fixed mass increase between the resulting labelled and 
unlabelled peptides, because the number of nitrogen atoms in amino acids ranges 
from one (as in glycine) to four (as in arginine). 
The incorporation of ^^ N into proteins and peptides is advantageous because it 
can also be used for structural proteomics^® by following the phase shifts using 
nuclear magnetic resonance (NMR). This has provided insight into biochemical 
functions that were not detectable from sequence analysis alone. The ^^N 
metabolic labelling technique has been limited to microorganisms, because the 
isotopically substituted media is difficult and expensive to produce for the 
mammalian system^®. Though, Conrads at a/.^° successfully labelled bacteria and 
mammalian cells in culture, the resulting peptide pairs were analysed using liquid 
chromatography - fourier transform ion cyclotron resonance (LC-FTICR) to obtain 
relative quantitation. The approach of ^^ N metabolic labelling has been 
demonstrated to be an accurate quantitation methodology and which has been 
applied to various modes of separation^V 
1.2.1.2 ^^ C Enrichment and Depletion 
Metabolic labelling using ^^ C isotopically modified media has been reported^^, 
though this method has not been extensively employed for protein and peptide 
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quantitation. The technique involved positive and negative labelling for the 
quantitation of peptides by isotope dilution, in which one sample was grown in ^^ C 
at 99.98% enrichment (^^C-depleted, negative labelling) and the other grown in 
^^C-enriched (^^C-dep!eted, positive labelling) media prior to analysis by matrix 
assisted laser desorption ionisation - time of flight - mass spectrometry (MALDI-
TOF-MS). Carbon is an ideal stable isotope to use rather than nitrogen, because 
the two most abundant elements found in living organisms are carbon and 
hydrogen. ^^ C carbon can be supplied in two forms for stable isotope labelling; 
either as pure carbon sources to synthetically defined media for microbes, or as 
carbon dioxide for photosynthetic organisms. Recently, ^^ C metabolic labelling 
using carbon has been applied to the field of quantitative metabolomics^^' 
An advantage of using either ^^ N or ^^ C for isotopic labelling is that the methods do 
not rely upon one single amino acid residue for labelling, as is the case with other 
stable isotope labelling methods such as ICAT. In addition. ^^ N or ^^ C labelled 
peptides do not display significant isotope dependent shifts compared with their 
naturally labelled counterparts during chromatography hence, improving relative 
quantitation. The popularity of these metabolic labelling methods has resulted in 
the development of software tools such as TurboSequest and Xcalibur (Thermo 
Finnigan, San Jose, USA) to allow quicker identification and quantitation. 
1.2.1.3 Stable Isotope Labelling bv Amino Acid in Cell Culture 
The technique of metabolic labelling was further improved by Ong et a/.^ ® for the 
relative quantitation of mammalian cells. Mammalian cells cannot synthesise a 
number of amino acids, which must be supplied in the cell culture medium as free 
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amino acids to support cell growth. The stable isotope labelling by amino acid in 
cell culture (SILAC) technique involves incorporation of deuterium enriched leucine 
(Leu-^Ha) and normal leucine in the medium respectively. The samples are 
combined and the resulting analysis performed by 2-DE gel separation with LC-
ESI-MS detection. 
The advantage of using amino acid incorporation of stable isotopes is that proteins 
in mammalian cells can be quantitated. Leucine was selected because it is the 
most abundant amino acid at 9.4% of total amino acid abundance. This allows 
68% of the tryptic peptides to be differentially labelled, compared to 20% of tryptic 
peptides using the ICAT method (calculated on the basis of the relative abundance 
of cysteine and leucine residues, and an average length of 14 amino acids for 
tryptic peptides that can be sequenced by mass spectrometry^®). Compared to the 
original method of metabolic labelling there is a fixed increase in mass between 
labelled and unlabelled tryptic peptides that is proportional to the number of 
leucine residues incorporated. Ong a/.^ ® reported the complete incorporation of 
the stable isotope labelled amino acid after five doublings of the cell lines. 
Furthermore, it was found that the enriched growth media did not alter cell growth, 
cell morphology, or doubling time. However it was noted that incorporation times 
varied from cell line to cell line, so longer incubation times may be necessary^®. 
The SILAC approach allows specific amino acids to be incorporated for relative 
quantitation, so the proteome coverage can be reduced by incorporating cysteine 
or tryptophan residues. In addition, amino acids can be labelled with either ^H, ^^C, 
^^N, or ^®0. Deuterium labelling is the obvious choice, because it is a cheaper 
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label, however, its physico-chemical properties are different from hydrogen, which 
results in an isotope effect during reverse phase liquid chromatography^^ which 
leads to variations in Isotope ratios. This hydrogen isotope effect is caused by 
early elution of deuterated peptides compared to non-deuterated counterparts^®. 
When peptides elute at different times the ionisation conditions may differ, 
particularly during gradient elution, which can cause bias in the relative 
quantitation. 
A second generation SILAC approach has been developed to overcome the 
isotope effects of using deuterated leucine. The method uses ^^Ce-Arginine as a 
label, the advantage being that trypsin cleaves after the arginine and lysine 
residues, so generates peptides with these residues at the carboxyl terminus in 
equal abundance^^. 
A limitation of the metabolic labelling technique is that the procedure has only 
been applied to organisms that can be grown in defined media, such as unicellular 
organisms and cells in culture as described previously. However, unique strategies 
have been recently employed for the relative quantitation of multicellular 
organisms by the complete labelling of potato plants^'', the nematode 
(Caenorhabditis elegans) and the frultfly (Drosophila melanogasterf^. Plants were 
labelled using K^^NOa added to the growth media as the only source of nitrogen^^. 
Krijgsveld et a/.^ ® used a two step labelling procedure to incorporate stable 
isotopes into proteins and peptides, by growing bacteria and yeast on ^^N-enriched 
media which were then used to feed the nematode and fruitfly respectively. 
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The incorporation of stable isotopes to a selected amino acid is an ideal method 
for quantitating proteins or natural cell lines because the method is inexpensive, 
analytically accurate, and simple to carry out. The stable isotopes are incorporated 
at the earliest possible stage, so experimental errors are minimised and mass 
spectrometric analysis does not discriminate between unknown(s) and internal 
standards because they both have the same ionisation efficiencies. The 
advantage of using amino acid stable isotope incorporation over the ^^ N metabolic 
labelling technique is that the isotope shift mass can be predefined (determined by 
which amino acid is incorporated) which facilitates peptide sequencing and 
identification. 
Metabolic labelling is a limited technique because it relies on proteomic samples 
derived from cell cultures, and cannot be applied to other samples of interest such 
as tissue samples or body fluids^^ When metabolic labelling is not suitable for 
analysis, alternatives such as proteolytic labelling or chemical labelling techniques 
have to be explored. 
1.2.2 Proteolytic Labelling 
Several procedures have been described for the incorporation of isotopic labels 
after proteolysis. Proteolysis incorporates oxygen atom(s) from the solvent into the 
C-terminus of the digested peptide using either or respectively. 
Mirgorodskaya et a/.^° and Yao at a/. ^\ describes the cleavage of protein in heavy 
(H2^®0) water with the other sample being cleaved in light (Hz^^O) water. This 
approach was used to label all proteolytic peptides and compare protein extracts 
from serotypes of adenovirus^. 
14 
The proteolytic labelling procedure is simple, because the stable isotope is not 
incorporated during protein synthesis, and all peptides are labelled. In addition, 
oxygen atoms of the C-terminus carboxylates do not exchange with the solvent in 
the absence of enzyme (trypsin). A drawback to this type of quantitation is that 
isotopic labelling occurs late in the sample preparation process, which can lead to 
incomplete labelling and unequal losses due to sample handling; also, many 
peptides cannot be enzymatically cleaved. In addition, the tryptic lysate results in a 
very complex sample which can cause problems during analysis. For example, a 
total Escherichia coli lysate would produce 132,768 peptides; a total yeast lysate 
produces 333,247 peptide fragments, and a total human digest would produce a 
nominal 2.641,532 peptides^V 
1.2.3 Chemical Labelling Strategies 
Chemical labelling or derivatisation of specific amino acid residues can be used to 
incorporate both stable isotopes for relative quantitation and to attach affinity tags 
to specifically enrich and isolate peptides. Considering that there are twenty 
natural amino acids, the selection of functional groups to be tagged is rather 
limited. This section will describe stable isotope labelling techniques on whole 
proteins and peptides. 
Recent reviews by Leitner a/.^ '^ ^ discusses isotopic tagging strategies of 
various amino acids, primarily for proteomic analysis. Cysteine is frequently 
labelled because the thiol group can be specifically modified by reagents 
containing iodoacetyl or vinyl functionalities. These reagents have been in use for 
a long time to alkylate free cysteine residues after the reduction of the disulphide 
bonds. In addition, cysteine is a rare amino acid with an average relative 
abundance of 1.1% across several species^. Tagging of other amino acids has 
also been extensively described, such as lysine residues after tryptic digestion, or 
N-terminal amines^. 
1.2.3.1 Isotope Coded Affinitv Tag 
Stable isotope quantitation strategies have been demonstrated, with a wide range 
of residue labelling specificities and with several different reagents, to provide 
relative quantitation using a variety of technologies. Isotope coded affinity tag^ 
(ICAT) developed by Aebersold and co-workers has made the biggest impact in 
proteomics since the advent of soft ionisation mass spectrometry. 
Figure 1-4 shows the structure of the first generation ICAT reagent split into three 
distinctive functional groups. The iodoacetamide group is used to incorporate 
stable isotopes into proteins or peptides via a selective aikylation of the thiol 
groups of cysteine residues at a pH of about 7-8. The isotope coded region of the 
tag is used to distinguish between the two forms, the light form containing eight 
hydrogens and the heavy form containing eight deuteriums. The biotin moiety is 
used for specific isolation of labelled peptides by means of biotin-avidin affinity 
chromatography. 
The ICAT strategy for quantifying differential protein expression is based on the 
detection of the relative amounts of heavy and light reagents by mass 
spectrometry (MS). The ICAT reagent is added to two different cell states, one 
state is derivatised with the isotopicaliy light reagent, and the second state is 
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derivatised with the isotopically heavy reagent. The binding of the ICAT to the 
cystienyl residues on the proteins is performed via an alkylation reaction. 
ICAT Reagent: Heavy Reagent ICAT (X=deuterium) 
Light Reagent ICAT (X=hydrogen) 
HN NH 
Biotin group Linker 
Heavy or Light Region 
lodoacetamide group 
Thiol specific 
Figure 1-4 Structure of the first generation isotope coded affinity tag (ICAT) reagent. The X 
functional groups represents whether the compound is deuterated or not. 
The alkylation reaction Is highly specific, and is limited to the thiol group of each 
cysteine residue. The two samples are then combined together and digested using 
protease to generate peptide fragments, of which some are tagged with the ICAT 
reagent. The next step is to separate and isolate the tagged peptides (peptides 
containing cysteine) from the untagged peptides by using avidin affinity 
chromatography. The biotinylated peptides selectively bind to avidin because of 
the high affinity for binding between biotin and avidin. This separation step allows 
biotinylated peptides (tagged) to be isolated from compounds that were not 
biotinylated (untagged). The isolated peptides from the affinity chromatography are 
then separated via reverse phase pLC, and analysed by mass spectrometry. 
The mass spectrometer can be used in dual mode for relative quantitation and 
sequencing of the peptides. The mass difference between the heavy (deuterated) 
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and light (hydrogenated) is 8 Da, therefore, pairs of peptides with identical peptide 
sequences only differ physically and not chemically so chromatographic 
separation can be used. Relative quantitation is achieved by comparing the signal 
intensities for the pairs of peptide ions of identical sequence that are tagged with 
either the heavy or light form of the ICAT reagent. 
The ICAT strategy has the ability to provide relative quantitation to a degree that 
has not been surpassed, and, due to the success of the ICAT reagent many other 
similar reagents have been produced and are currently being used for protein 
relative quantitation. These second-generation compounds have been produced in 
light of some shortfalls experienced with the first generation ICAT reagent.. 
A distinct advantage of the ICAT strategy is the selective isolation of the 
biontinylated cysteine residues on peptides using biotin/avidin affinity 
chromatography. The strong binding between the biotin tag and avidin provides an 
enrichment of peptides of interest and the selective nature of the ICAT reagent 
reduces the complexity of the peptide mixture. For example, the tryptic digest of 
the entire yeast proteome (6.113 proteins) produces 344,855 tryptic peptides, but 
only 30,619 of these peptides contain a cysteine residue^. However, the 
dependence on the biotin/avidin binding system for the isolation step may lead to 
additional difficulties, such as non-specific binding of peptides and incomplete 
elution of undesirable peptides. 
The cysteine specificity of the ICAT reagent can be a notable disadvantage 
because one out of seven proteins in the human proteome does not contain the 
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cysteine residue^^. The work carried out by Gygi et ai used a yeast cell 
{Saccharomyces cerevisae) that contained 30.619 cysteine containing peptides 
which provided -92% coverage of the proteome^®. 
Another significant problem wflth the first generation ICAT reagent is that 
separation through a reverse phase column can lead to a well-known isotope 
effect, in which the deuterated peptide elutes earlier than the non-deuterated 
counterpart^^. This effect can lead to large variations in measured isotope ratios 
because of variations in ionisation during gradient elution. The hydrogen isotope 
effect can lead to peptide expression errors, hence, protein expression errors of 
greater than 25%. which have been reported, though the isotope effect was 
addressed by Smolka et a/.^ by utilising two dimensional gel electrophoresis (2-
DE) separation for ICAT tagged peptides followed by MS analysis. The research 
showed that there was co-migration of the heavy and light forms of the ICAT 
reagent on the 2-DE gel. Another critical issue was that the relatively large biotin 
tag would also fragment under collision induced dissociation (CID) MS, 
complicating the mass spectra and hindering computer aided interpretation. 
1.2.3.2 Second Generation Isotope Coded Affinitv Taos 
Second generation ICAT reagents were synthesised to address the issues with the 
original ICAT reagent (Figure 1-5a) described in 1.2.3.1. Zhou et al.^^ described 
the use of a solid phase capture and release method to introduce stable isotopes, 
in addition to isolating the tagged peptides (Figure 1-5c). The tag was attached to 
a solid phase resin containing pore glass beads consisting of a photo-cleavable 
linker, an isotope tag (either heavy or light), and a specific reactive group. The 
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advantage of using this method was that the peptides were isolated and tagged in 
one step, which meant minimal sample handling. The photo-cleavable linker 
allowed a smaller tag to be used (170 Da compared to 442 Da for the original 
ICAT reagent), hence improving identification during CID MS. A side-by-side 
comparison of the solid phase and solution phase methods indicated that more 
proteins were identified from Saccharomyces cerevisae using the solid phase 
capture-release ICAT method''^. 
However, the significant isotope effect remains when chromatography is used 
because of the hydrogen/deuterium isotope effect. This was addressed by Qui et 
al.^^ who synthesised an acid labile isotope coded extractant (ALICE) shown in 
Figure 1-5d, wherein the reagent incorporates nine ^^ C atoms as the heavy 
reagent, this permits the ^^C heavy/light-modified peptides to co-elute by reverse 
phase chromatography, making relative quantitation much more reliable. In 
addition, they used a solid phase capture and release method to enrich Cys-
containing peptides and a acid labile linker was used to reduce the mass of the tag 
for MS. A similar tag was developed by Applied Biosystems Inc. (Foster City, CA) 
which contained ^^ C atoms as the isotopic label and with an acid cleavable biotin 
linker (Figure 1-5b). The method was identical to the original ICAT method except 
that, as an additional step, the biotin group was cleaved off prior to MS. A, 
schematic of the different types of tagging reagents described are shown in Figure 
1-5. 
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Figure 1-5 Summary of the available ICAT based tagging reagents (a-d) and comparison to 
(e) a standard stable isotope tag for peptides: a) First generation ICAT, with biotin affinity 
group, hydrogen or deuterium based tag and a iodoacetamide reactive group introduced by 
Gygi ef a/.^; b) Second generation ICAT with an acid cleavable biotin tag, carbon based tag 
and a iodoacetamide reactive group introduced by Applied Biosystems; c) Second 
generation ICAT with an photo-cleavable solid phase group, hydrogen or deuterium based 
tag and a iodoacetamide reactive group introduced by Zhou ef aiP\ d) Second generation 
ICAT with an photo*cleavable solid phase group, hydrogen or deuterium based tag and a 
iodoacetamide reactive group (ALICE) introduced by Qui ef a/.^°. Modified from Tao ef a / / \ 
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1.2.3.3 Mass-Coded Abundance Tagging 
In 1999 it was reported that MALDI-TOF ionisation is biased towards peptides that 
contain arginine residues compared to peptides containing lysine residues. The 
detection intensity was found to be 4-18 times more intense for arginine than 
lysine^^. Different research groups"*^^ used this phenomenon to derivatise the 
lysine group of terminated tryptic peptides through the guanidination of the £-
amino group of the C-terminal. The derivatisation converted the lysine into a 
homoarginine which exhibits enhanced intensities using MALDI-TOF for protein 
identification. 
Cagney and Emili '^, introduced the mass-coded abundance tagging (MCAT) 
abbreviation, applied the guanidination derivatisation procedure and demonstrated 
its use with LC/MS-MS-MS for the relative quantitation of proteins in mixtures. The 
strategy for MCAT involves digesting two samples using trypsin, and the resulting 
tryptic peptides of one of the samples is modified with 0-methylisourea for the 
guanidination of the lysine to homoarginine. while the other sample remains 
unmodified. The two samples are combined together in a 1:1 ratio, and seperated 
by reversed phase capillary LC before being introduced into an ESI source for MS 
and MS/MS analysis. The resulting spectra are used to compare ion intensities for 
relative quantitation. 
Two qualitative differences are apparent between the MCAT and ICAT methods. 
The MCAT derivatisation adds a 42 Da difference between two identical peptides 
while ICAT adds a 8 Da difference between the light and heavy forms of the 
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peptides. Additionally, ICAT is performed on intact proteins prior to digestion 
whereas MCAT guanidination is conducted on tryptic digested peptides. 
The main advantage of using the MCAT method is that the reaction of unhindered 
peptides proceeds to completion in 1hr at 37°C, which is ideal for high through-put 
analysis. The disadvantage is that relative quantitation does not take into account 
differences in ionisation efficiency between lysine (untreated) and homoarginine 
(treated sample), which can bias the peptide ratio. 
1.2.3.4 N-Terminal Labellino 
In addition to specific amino acid residues such as cysteine and lysine, the primary 
amine group of the N-terminal can also be targeted. The method developed by 
Regnier and co-workers'*^' '*® is the acylation of primary amino groups of peptides, 
after tryptic digestion, using either /V-acetoxysuccinimide or /V-acetoxy-
[^Dalsuccinimide. The method employed a global internal standard strategy 
(GIST), due to the fact that all peptides, regardless of composition, were labelled. 
However, this can result in a very complex sample so, in order to reduce sample 
complexity, the group introduced a capture/enrichment strategy whereby peptides 
that contain Cys and His were isolated^®. This allowed a greater proportion of the 
proteome to be analysed compared to the ICAT method, though the authors failed 
to mention the percentage of coverage over the proteome. 
1.2.3.5 Summarv of Relative Quantitation Technicues 
Relative quantitation has been well documented in several reviews^®' The 
"pros" and "cons" of current methods are summarised in Table 1-1. The most 
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fundamental factor to be considered when selecting a method or reagent, is the 
accuracy of the relative quantitation. It is important to note the observation by Gygi 
et a/.^, when discussing the error associated with metabolic labelling method 
using ^^N. "The percentage error of the experimental technique was found to be 
excellent (±10%)." 
The large errors observed in these experiments were not caused by the tagging 
method but the resulting method(s) of detection and isotope ratio analysis. 
Molecular mass spectrometry, when used for relative quantitation, has proved to 
exhibit poor linearity, precision and accuracy. Due to the poor accuracy and 
precision it is difficult to determine small differences in protein expression between 
control and disease states. 
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Table 1-1 Summary of proteome relative quantitation methods. 
Labelling method Overview of methodology 
Change in 
peptide mass 
Isotope 
coding Advantages Disadvantages 
Bi
ol
og
ic
al
 in
co
rp
or
at
io
n 
N '^ Labelling'^ Growth on general or 
isotopic media 
Depends on 
composition of 
peptides 
Earliest isotope incorporation 
Samples combined at earliest stage 
Complete proteome coverage 
Expensive 
Limited to cells that can be grown in 
cell cultures 
Complex samples require fractionation 
prior to MS 
Bi
ol
og
ic
al
 in
co
rp
or
at
io
n 
Incorporation of 
isotope coded AA from 
growth media 
Choose specificity of isotope 
incorporation 
Can cover entire proteome 
Earliest incorporation and sample 
combination 
Expensive 
Limited to celts that can be grown in 
cell cultures 
Complex samples require fractionation 
prior to MS 
Ch
em
ic
al
 in
co
rp
or
at
io
n 
First generation 
ICAT reagent^ ^ Cys residue 
modification followed 
by selective capture 
8 Da for labelled 
Cys residue WH 
Reduced sample complexity by 
enrichment of Cys-peptides 
Universally applicable 
Limited to proteins containing Cys 
Isotope effect affects chromatography 
Non-Cys containing peptides enriched 
by avidin chromatography 
Biotin tag complicates MS analysis 
Ch
em
ic
al
 in
co
rp
or
at
io
n 
Acid cleavable ICAT 
reagent'*" 
9 Da for labelled 
Cys residue 
Reduced sample complexity by 
enrichment of Cys-peptides 
Universally applicable 
Cleavabte biotin tag 
Limited to proteins containing Cys 
Non-Cys containing peptides enriched 
by avidin chromatography 
Ch
em
ic
al
 in
co
rp
or
at
io
n 
MCAt*^ Guanidination of C-terminal lysine 
42 Da for 
labelled 
peptides 
No stable isotopes required 
Inexpensive 
Universally applicable 
Complex samples require fractionation 
prior to MS 
Require multiple derivatisation steps 
Ch
em
ic
al
 in
co
rp
or
at
io
n 
Enzymatic Digestion C-terminal modification during proteolytic 
cleavage 
2-4Da 
dependant on 
peptides 
16Q^18Q 
Complete proteome coverage 
Universally applicable 
Simple derivatisation 
The 2-4Da mass difference limits the 
analysis of larger peptides 
Complex samples require fractionation 
prior to MS 
Ch
em
ic
al
 in
co
rp
or
at
io
n 
Derivatisation of N-
and C- terminus '^*"" 
Tagging of stable 
isotopes are 
proteolysis 
Dependant on 
tag 
WH Universally applicable 
Complete proteome coverage 
Complex samples require fractionation 
prior to MS 
No selectivity - large dynamic range 
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1.3 Proteomic Technology 
Traditionally, proteomic technology has focused on protein identification using 
Edman sequencing to obtain N-termlnal amino acids sequences^^. However, 
molecular mass spectrometry is now the method of choice to obtain structural 
information, though Edman sequencing still finds a role in proteomics because of 
the well established nature of the technique. 
The basic instrumental analytical requirements in proteomic analysis are high 
sensitivity, high resolution, high throughput and high-confidence in protein 
identification. In addition, proteins should be quantified and post-translational 
modifications identified. 
The following general considerations should be taken into account during 
proteome analysis (Figure 1-6): 
o Sample preparation - whether samples require treatment such as 
enrichment, extraction from matrix, reduction of sample complexity, tagging 
of stable isotopes. 
« Sample separation - baseline resolution of analytes, time for analysis, 
fractionation to reduce complexity. 
o Sample detection - identification, qualitative or quantitative, protein 
expression, mass resolution. 
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Figure 1-6 Summary of technologies used at each step of proteomic analysis of intact 
proteins or complex mixtures of peptides. 
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1.3.1 Separation Technology in Proteomics 
In order to reduce sample complexity prior to mass spectrometry one of two 
approaches can be used: (1) proteins are separated, then digested - top down 
proteomics^; (2) or bottom up proteomics where a complex protein mixture is 
digested then the resulting peptides are chromatographically resolved, also known 
as shotgun proteomics^^. Whichever method of analysis is selected the separation 
plays an essential role in the analysis. 
Several separation approaches have been employed for the analysis of complex 
mixtures prior to mass spectrometric analysis. These separation methods range 
from high through-put techniques such as chromatography to high peak capacity 
methods such as electrophoresis. 
1.3.1.1 One Dimensional Gel Electrophoresis 
The most common application of one dimensional gel electrophoresis (1-DE) is the 
characterisation of proteins. A purification step to reduce the complexity of the 
sample is necessary because of the limited resolving power of 1-DE. The limited 
resolution is due to the way proteins are separated, they are separated in one 
dimension by mass, with a mass range of 10 to 300k Da being separated. 1-DE 
has the advantages of being simple and a very reproducible method of separation. 
1.3.1.2 Two Dimensional Gel Electrophoresis 
For the last 25 years, two-dimensional gel electrophoresis (2-DE) has been the 
method of choice for the analysis of complex protein mixtures (e.g. crude cell 
lysate), and can be used to separate as many as 5000 different proteins in a single 
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experiment^. The technique separates proteins in two dimensions: the first 
dimension resolves proteins depending on their net charge, separating proteins 
within an isoelectric point (pi) range of 3.5-10; and the second is based on 
molecular weight. Once separated, samples can be visualised by staining the 
proteins with silver stains, fluorescent stains or coomassle blue. Once located 
proteins can be eluted from the gel for analysis. 
The primary application of 2-DE is in protein expression profiling, where protein 
samples can be compared qualitatively and quantitatively. The appearance or 
disappearance of a spot can indicate the difference between normal and diseased 
cell. The intensity of the spots can also provide quantitative information though it is 
not reliable as other techniques such as stable isotope labelling. 
An improvement in protein expression profiling has been achieved using 
differential gel electrophoresis (DIGE). The technique uses fluorescent tagging of 
two protein samples using two different amine reactive dyes. The dyes are 
designed to ensure that the proteins have the same mobility regardless of which 
dye is attached. The samples are then run on the same gel plate and compared by 
digital imagining using the optimum fluorescence of the respective dyes. The 
technique circumvents the need to compare several 2-DE gels. 
A major advantage of 2-DE is the ability to resolve proteins that have undergone 
certain post-transitional modifications, because such proteins undergo a change in 
net charge as well as a change in mass. An example of this is protein 
phosphorylation, where the phosphorylated protein can be resolved from its non-
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phosphorylated form as several spots on the 2-D gel rather than a single spot for 
the non-phosphorylated protein^®. 
Developments of 2-DE over a period of years has resulted in an increase In 
reproducibility through the introduction of immobilised pH gradients, which 
improves resolution. However, large and hydrophobic proteins still cannot be 
resolved because they cannot enter the gel in the first dimension, in addition, to 
highly acidic and basic proteins®°. 
1.3.1.3 Liguid Chromatography 
Liquid chromatography (ion exchange, size exclusion, affinity and reverse phase) 
and electrophoretic separations in the liquid-phase (capillary zone and free flow 
electrophoresis) are well established techniques that have been used to purify or 
separate organic molecules, DNA or peptides and proteins. 
1.3.1.4 Reversed Phase LC 
Reversed phase chromatography is used to describe the state in which the 
stationary phase is less polar than the mobile phase®\ A chemically bonded 
octadecylsilane (CDS. C i 8 ) , an n-alkane chain, is the most frequently used 
stationary phase. Shorter alkyi groups including C4, Cs (which is used for protein 
separation) and also cyclohexyl and phenyl groups provide other alternatives to 
aid chromatographic separation of compounds. The mobile phase (eluent) 
normally contains a mixture of water or aqueous buffer solution with water miscible 
solvents, such as methanol and acetonitrile. Typically, acid (formic, acetic or 
thfluoroacetic) is added to the mobile phase to render all of the component 
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proteins and peptides positively charged and to reduce unwanted ionic interactions 
with the stationary phase. In addition, the type of mobile phase used for 
separations can have a large effect on the retention and it can also promote or 
suppress ionisation of the analyte molecules. 
In reversed phase chromatography partition occurs between the bonded organic 
phase and mobile liquid phase. Consider the following separation of a two 
component mixture, component A has the same interaction with the adsorbent 
surface as the eluent, and component B has strong interaction with the stationary 
phase. An injection of the sample into the mobile phase, generally a narrow band 
(5 - 20 \iL injection volume), results in the sample flowing with the mobile phase 
onto the column. Molecules of component A will interact with the adsorbent 
surface and be retained to the same extent as eluent molecules. Thus, as an 
average result, component A will move through the column with the same speed 
as the eluent. Molecules of component B, being more strongly adsorbed on the 
stationary phase will interact with it much longer. Thus, they will move through the 
column slower than the eluent flow. This results in two distinct separated peaks. 
The first peak to elute will be due to component A, followed by a second peak to 
elute, component B. 
Retention of the analyte depends on its affinity for the mobile phase and stationary 
phase, so extensive method development is often necessary to enable adequate 
resolution between analytes. As a general rule for reversed phase 
chromatography, polar substances interact better with the mobile phase and elute 
first, and as the hydrophobic character of the analyte increases, retention 
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increases^V Separation efficiency of the stationary phase is determined on the 
adsorbent particle sizes, porosity, pore size, column size, shape, and packing 
performance. Typically particle size of 3 and Spm are used for separation involving 
proteins, peptides and other small molecules, however, reducing the particle size 
from 5 to 3pm for the same column length can increase separation efficiency by 
30-40%®^. In general, the longer the component is retained on the column, the 
broader its zone (peak on the chromatogram). 
1.3.1.5 Multi-dimensional Liouid Chromatography 
One dimensional-liquid chromatography (1D-LC) techniques are routinely used for 
protein and peptide identification, though applications in proteomics are restricted 
by the complexity of the sample. A typical proteolytic digestion can yield hundreds 
of thousands of peptides, all of which must be separated. This exceeds the 
analytical range of most 1D-LC methods because of insufficient peak capacity, so 
this has led to development of high resolution separation techniques such as multi-
dimensional chromatography. 
In order to improve separation and resolution of proteomic samples, multi-modular 
combinations of high performance liquid chromatography (LC), ion-exchange 
chromatography (IC), size exclusion chromatography and capillary electrophoresis 
(CE) have been developed. Most multidimensional systems are coupled with mass 
spectrometry so the choice of the second dimension is limited to reversed phase 
chromatography. The choice of the first dimension separation must be 
complementary to the reversed phase separation, e.g. CE-RPLC, IC-RPLC. 
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A limitation to using multidimensional chromatography systems is the requirement 
for two or more valves and pumps, and more complex 2D-LC systems cannot be 
automated due to the requirement for multiple sample loops, splits and switching 
valves to transfer samples between columns. This problem was solved vwth the 
creation of biphasic columns®^, capillary columns packed with strong cation 
exchange (SCX) resin followed by RP resin, thereby allowing the automated 
analysis of proteomic separations. Biphasic columns are the key component in the 
development of multidimensional protein identification technology (MudPIT), which 
has been the most successful for the global analysis of complex protein mixtures. 
The elution profile contains typical eluents used for reverse phase chromatography 
(water, acetonitrile and an acidic modifier), in addition to SCX eluents such as 
moderate amounts of methanol, organic solvents or ionic species in the form of a 
buffer. This allows the separation of compound in both reverse and ion exchange 
phases respectively 
Washburn et al.^ described the use of MudPIT and assigned over 5.000 
separated peptides to 1484 proteins in Saccharomyces cereviseae using SCX 
chromatography in the first dimension followed by RPLC in the second dimension. 
Using the same criteria described by Washburn the separation of more than 
12,000 unique peptides and more than 1600 unique proteins was achieved from a 
whole yeast lysate®^. 
1.3.2 Mass Spectrometry Technology in Proteomics 
Mass spectrometry is capable of providing information about: (1) the elemental 
composition of analyte; (2) structures of inorganic, organic, and biological 
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molecules; (3) the qualitative and quantitative data; and (4) isotopic ratios of atoms 
in samples. 
1.3.2.1 Electrosprav lonisation Mass Spectrometry 
Electrospray ionisation mass spectrometry (ESI-MS) which was first described in 
1984 by Fenn and co-workers^®- who successfully demonstrated the basic 
experimental principles and methodologies of the ESI technique, including soft 
ionisation of involatile and thermally labile compounds, multiple charging of 
proteins and intact ionisation of complexes. Since then, LC-ESI-MS has made 
rapid progress with extensive literature, many reviews, special journal issues and 
books, and has now become one of the most important techniques for analysing 
biomolecules such as peptides, proteins and oligonucleotides. 
In ESI-MS, the sample is typically dissolved in a volatile solvent and is delivered to 
the ionisation source through a narrow metal microcapillary tube into the orifice of 
the mass spectrometer, where a potential difference between the capillary and the 
inlet to the mass spectrometer results in the generation of a fine aerosol of analyte 
containing droplets. As the solvent evaporates the droplets decrease in size 
resulting in the formation of desolvated ions; this evaporation leaves positive ions 
originating from the addition of one (MH"") or more [(M + n\\)^\ protons to the 
analyte®®. These ions are then extracted into the high vacuum of the analyser 
system of the mass spectrometer where the ions are separated according to their 
m/z ratio. 
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Acid modifiers such as formic acid have been used in LC eluents when combined 
with ESI-MS to provide additional benefits to mass spectrometry for example in 
peptide analysis acid modifiers can protonate or form ion pairs with the peptides 
and elute them in sharper chromatographic bands. Also due to the excess protons 
available when using acidic modifiers, peptides will be readily protonated forming 
MH* ions or even [(M + nHf*] ions, thus promotes efficient ionisation in the ESI 
source. However care must be taken when selecting acid modifiers, trifluoroacetic 
(TFA) acid can readily form ion pairs and produce sharper chromatographic 
bands, however TFA can also reduce ionisation has it can "soak up" a lot of 
protons during analysis. 
1.3.2.2 Matrix Assisted Laser Desorption/lonisation Mass Spectrometry 
Matrix-assisted laser desorption/ionisation (MALDI) was developed by Karas and 
Hillenkamp^^. In 1987, it was shown that if a low concentration of analyte was 
mixed with a small organic molecule (matrix) onto a probe or metal plate and 
introduced into a pulsed laser beam. A substantial burst of ions was produced with 
each laser pulse. This formed the foundation of modern MALDI based techniques. 
In MALDI-MS the sample is incorporated into an energy absorbing matrix such as 
2,5-dihydroxybenzoic acid or a-cyano-4-hydroxycinnamic acid. The mixture is then 
applied to metal plates, such as the 96-welI format, dried and then subjected to a 
pulse of UV laser light. The specific target of the laser is directed into the vacuum 
of the instrument. The ionisation of the sample predominately results in the 
formation of protonated molecular ions (MH*). 
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A time of flight (TOP) mass spectrometer is traditionally used in conjunction with 
MALDI. The time taken for an ion to traverse the flight tube is determined by its 
m/z ratio, the lighter ions travelling faster than the heavier ions. Improvements in 
mass accuracy have been achieved by developments such as the reflectron lens 
and delayed extraction, which result in an increase in mass resolution. A major 
advantage of MALDI is that samples can be directly analysed without any 
purification, after digestion from 2DE gels. Typically MALDI analysis has been 
used for quantitative analysis such as the identification of proteins and peptides. 
A different approach using MALDI-MS for peptide fractionation and identification is 
the use of ProteinChip technology (Ciphergen) known as Surface Enhanced Laser 
Desorption lonisation (SELDI)-MS. This employs a surface capture method using 
either antibodies or chemically modified surfaces to bind specific classes of 
proteins. 
1.3.2.3 Inductivelv Coupled Plasma Mass Spectrometrv 
Atmospheric-pressure inductively coupled plasmas (ICPs) are flame-like electrical 
discharges that have transformed the practice of elemental and isotopic ratio 
analysis^°. The argon ICP has now become the most widely used atomic 
spectroscopy source in routine analytical chemistry. In 1983 Date and Gray^^' 
and Houk and Fassel^^ developed the use of ICPs as an ion source for mass 
spectrometry. 
Liquid sample introduction is the most common way of introducing a sample into 
the ICP (Figure 1.7). Typical introduction systems consist of a nebuliser. where the 
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liquid sample is converted to an aerosol, and a spray chamber which transports 
the aerosol into the plasma, where the desolvation - vaporisation - atomisation -
excitation - ionisation processes occur. The hot plasma gas is transmitted into a 
low pressure interface containing both sampler and skimmer cones. The ions 
formed in the plasma are focused through a lens system and transmitted to a 
mass analyser prior to detection by either an ion counting or an analogue detector. 
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Figure 1-7 Schematic of a quadrupole ICP-MS Instrument 
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1.4 Inductively Coupled Plasma Mass Spectrometry in Proteomics 
Since its introduction in the early 1980's, ICP-MS has been widely used for trace 
element detection and speciation of inorganic species. However, recently ICP-MS 
has been increasingly used in the field of proteomics because it can provide 
complementary information on metal protein complexes or metal dependent 
biochemical pathways. Molecular mass spectrometry alone cannot provide 
information on these processes, and ESI-MS detection limits suffer when salt rich 
real-world samples are analysed. Also, the ionisatlon efficiency of ESI-MS is 
analyte specific so an internal standard is required. Likewise, information on metal-
protein interactions is often lost In the gas phase during MALDI-MS^'* 
The advantages of using elemental mass spectrometry ICP-MS are: large linear 
dynamic range; low detection limits; selective for most elements in the periodic 
table; detection independent on structure and matrix; ease of coupling with all 
forms of chromatography; high throughput; mass balance; capable of accurate and 
precise isotope ratios. However. ICP-MS detection has still not been utilised to its 
full potential in the analysis of protein and peptide based samples compared to 
organic mass spectrometry. Most likely because it cannot be used to detect the 
major constituents of proteins or peptides namely C, H, N and O. These elements 
have extremely high background signals because they are either present in the 
sample matrix, solvents used during sample introduction, or atmospheric air 
entrained in the plasma. Hence, ICP-MS is generally limited to the element 
specific detection of bio-organic compounds containing a hetero-atom such as P, 
S, Se, Br, CI, I, a metal or metalloids. 
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Past and current research into life sciences involving ICP-MS has primarily 
focused on the speciation and quantitation of organic molecules where a hetero-
atom is incorporated into the molecule or metal complex, such as 
metalloproteins'^. Improvements in instrumentation have recently allowed the 
routine analysis of phosphorus and sulphur'®- in biological samples by employing 
a quadrupole ICP-MS with a collision/reaction cell or a sector field (SF) instrument. 
Current strategies on offer using ICP-MS detection of metalloproteins, proteins 
and peptides from various biological samples using several approaches have been 
comprehensively reviewed''*" However, the analysis of metalloproteins, 
phosphorous and sulphur covers only a small aspect of the proteomic challenge. 
For ICP-MS to be used more extensively in life sciences applications there is a 
requirement for methods that can incorporate elemental or isotopic species into 
the organic molecules. 
1.4.1 Speciation of Proteomic Samples 
Various separation techniques have been coupled with ICP-MS for both multi-
element and elemental speciation analyses, including liquid chromatography, gas 
chromatography. supercritical fluid chromatography and capillary 
electrophoresis®^. Size exclusion chromatography (SEC) has been most utilised 
for proteomic speciation and ICP-MS analysis, primarily as a first step in studies 
involving metal containing proteins such as seleno-proteins, metallothioneins. and 
metalloproteins. 
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1.4.2 Natural Heteroatom Peptides and Proteins 
With improvements in instrumentation over the last decade, the analysis of 
naturally occurring heteroatom analysis has been achieved. Elements such as 
S,P. or Se, have been readily quantitated using a variety of different methods 
involving either quadrupole ICP-MS or high resolution ICP-MS. 
1.4.2.1 Sulphur 
The majority of sulphur containing cysteine amino acid residues are found in a 
specific group of proteins known as Metallothioneins. The difficulty in measuring 
sulphur (m /2 31.972) for quantitative analysis is mainly due to the high background 
counts from the ^®0^®0 interference at m/z 31.989. In order to spectrally resolve 
the interference from the main sulphur isotope a resolution of 2500 or greater is 
required. The quantitative analysis of proteins using LC-HR-ICP-MS was reported 
by Wind et a/.®^ for the sulphur-specific detection of insulin. 
1.4.2.2 Phosphorous 
Up to a third of all proteins and peptides in the human body are phosphorylated at 
any given moment. Given their importance in a variety of bodily functions a great 
deal of attention has been focused on the detection, and quantitation of this 
heteroatom. Several papers on the ICP-MS detection of phosphorous have been 
published^°- Wind's group have determined the degree of phosphorylation 
using the stoichiometric phosphorus to sulphur ratio (^V/^^S), determined in 
phosphopeptides containing cysteine and/or methionine residues from various 
proteins'^. This was then used to calculate the degree of phosphorylation using 
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protein/peptide sequence information. The major drawback of this approach is that 
the number of cysteine and/or methionine residues must be known. 
1.4.2.3 Selenium 
Selenium can be in found two amino acids selenomethionine and selenocysteine, 
analogues of methionine and cysteine. Selenocysteine is genetically encoded and 
considered to be the 21^* amino acid. Typically, ICP-MS detection of Se (m/z 74-
82) is plagued with interference from polyatomic ions. It was not until the advent of 
high resolution and/or reaction/collision cell technology for ICP-MS that selenium 
could be determined at the proteomic scale. The primary method applied by 
researchers for the determination and characterisation of selenium, is to use SEC-
ICP-MS to screen the sample for Se-containing fractions, then to characterise the 
Se-contalning bio-molecule by LC-ESI-MS/MS®^. These methods have been 
reported in many reviews concerning ICP-MS and proteomics^'*' 
1.4.2.4 Metallothioneins 
Metallothioneins (MT's) are a class of proteins that transport essential metals such 
as Cu and 2n as well as to remove heavy metals such as Cd. These MT's are rich 
in cysteine residues and typically contain 20 or so of these residues (up to 30% 
cysteine) which are primarily used for the binding of metals, thus making the 
protein an ideal candidate for ICP-MS detection. As with most ICP-MS methods 
involving proteins and peptides, the primary separation and purification is 
undertaken using SEC-ICP-MS, followed by chromatography of higher resolution, 
followed by ICP-MS and ESI-MS detection for characterisation. 
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1.4.3 Elemental Tags for Proteomics 
Some work involving the elemental tagging of organic molecules has begun to 
emerge but there has not been a concerted effort to design and evaluate 
isotopicaily labelled tags for element specific detection. Few methods exist for 
incorporating metal tags into proteins and one favoured method is via an 
immunoassay-based reaction to incorporate various metal tags such as gold-
tagged antibodies^' ^ or europium labelled antibodies®^. The recent development 
of metal-tagged antibodies has made it possible to use element specific detection 
In bio-techniques. However, antibodies containing metal tags have not yet been 
produced specifically for elemental analysis, so many of the tags used in the ICP-
MS detection have been produced for other purposes, such as the gold-tagged 
antibodies that are used in the localisation of cellular protein in electron 
microscopy®®. These tags seem ideal for the quantitation of antigens with ICP-MS 
detection because of the uniform size and number of the gold particles per 
antibody (conjugate). 
Lanthanide (Eu, Tb, Dy and Sm) tags have also been used in an automated 
fluoroimmunometric system (Wallac AutoDELFIA), e.g. isothiocyanate-benzyl-
DTPA-Eu, which can used to tag the free amino group on peptides. Such tagging 
procedures provide a simple efficient method for quantifying the specific proteins 
or peptides of interest. 
In recent years several methods have been developed involving chemical 
derivatisation to incorporate elemental tags into organic molecules for ICP-MS 
analysis. For example, in our laboratory the reagent 
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tris(trimethoxyphenyl)phosphonium (TMPP) has been used to tag various organic 
carboxylic acids with phosphorus to make them amenable to detection using ICP-
I^g 87. 88 Another chemical derivatisation method is the use of cyclic 
diethylenetriaminepentaacetic acid anhydride (cDTPA) which has been used for 
the chemical derivatisation of primary amines to allow the tagging of copper®^. The 
use of chemical derivatisation for the analysis of compounds in biological systems 
has been used in many other aspects of analytical chemistry vAih the prime 
example being molecular mass spectrometry and, in particular, the advent of 
isotopic tagging techniques for relative quantitation. Hence, it will only be a matter 
of time before elemental tags will be in used routine analysis for proteomic 
samples using ICP-MS. 
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1.5 Aims and Objectives 
The aim of this work is to investigate whether ICP-MS can be used to relatively 
quantitate peptides through heteroatom labelling and assess through isotope 
dilution mass spectrometry the methods accuracy and precision compared to 
current methods described in section 1.2. 
The objectives of this programme of study were, therefore to, develop techniques 
for: 
o The derivatisation of peptides through bifunctional chelating agents; 
o Labelling derivatised peptides with trivalent metals such as indium and 
europium; 
o Relative quantitation using isotope dilution mass spectrometry on labelled 
peptides; 
Primarily, the investigation will establish whether peptides can be derivatised and 
labelled with cDTPA and europium respectively. These labelled peptides then can 
be used to accurately determination the isotope amount ratio hence peptide ratio 
determinations performed using LC-ICP-MS. Different analytical techniques will be 
investigated to improve derivatisation and sample handling to improve the overall 
methodology for relative quantitation for complex samples. Electrospray lonisation 
Mass Spectrometry will be employed to characterise the various species formed 
during derivatisation and chelation in order to verify the complexes formed. 
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CHAPTER 2 DERIVATISATION OF PEPTIDES WITH CYCLIC 
DIETHYLENETRIAMINEPENTAACETIC ACID ANHYDRIDE 
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Chapter 2 
2 , INTRODUCTION TO LABELLING 
Chemical derivatisation (labelling) is an established analytical process that is used 
to modify the properties of an analyte molecule to facilitate detection using a given 
technique®^. Derivatisation has been used in many analytical disciplines to either 
enhance detection, such as in mass spectrometry^, ultraviolet/visible (UVA/is) and 
fluorescence spectroscopy, or to improve chromatographic properties in 
techniques such as gas chromatography (GC) and liquid chromatography. In this 
chapter, chemical derivatisation is used to incorporate elemental labels into 
peptides to facilitate element specific detection using LC-ICP-MS. 
Naturally occurring peptides, as opposed to peptides generated from protein 
digestion, have been largely overlooked in proteomics, even though they are 
important in a myriad of biological functions. For example, substance P a small 11 -
amino acid peptide with a sequence of Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-
Leu-Met, located in the central nervous system, acts as a neurotransmitter, and 
has been associated with several physiologic activities including the vomiting 
reflex, stress, mood disorders, smooth muscle contraction, vasodilation and pain^V 
Hence, it is essential to study naturally occurring peptides in a similar manner to 
that of proteins. 
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2.1 Elemental Labelling 
The analysis of biomolecules by ICP-MS has principally focused on compounds 
that contain a heteroatom such as sulphur, phosphorous or selenium, and this has 
limited the potential of element specific detectors in proteomic research. In 
addition, vjhen these elements are determined the use of either high resolution or 
expensive upgrades to ICP-MS such as a collision/reaction cell is required. Hence, 
alternative strategies for analysing biomolecules by ICP-MS must be considered, 
especially for those compounds that do not contain a heteroatom. 
Two approaches, namely chemical and biological labelling, have been developed 
for the incorporation of elements and Isotopes into biomolecules. As quoted by 
Qulnn et a/.®^ "As tags have not yet been developed specifically for elemental 
analysis, we have made use of immunoreagents that already contain element 
tags." Some research has just begun to emerge, however, there has not been a 
concerted effort to design and evaluate isotopically labelled tags for element 
specific detection. 
2,1.1 Biological Labelling 
One of the first methods for element labelling of proteomic samples was reported 
by Baranov et al.^ who developed an immunoassay coupled to ICP-MS detection 
to label specific antigens using gold tagged antibodies. The same research group 
introduced the use of lanthanide tags to be used in conjunction with 
immunoassays®^. These tags were not originally designed for ICP-MS detection 
but for the localisation of cellular proteins using electron microscopy or 
fluoroimmunometric analysis. The main advantage of using immunoassays for 
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elemental incorporation is that specific antigens can be isolated from their 
biological matrix, resulting in simplified detection and quantitation. 
Harrington et alP successfully labelled metalloproteins by growing cultures on 
media containing natural copper or enriched ®^Cu and suggested that there is 
potential for analysis by species specific isotope dilution analysis on proteins 
labelled in this manner. 
2.1.2 Chemical Labelling 
In recent years several methods have been developed involving chemical 
derivatisation of organic molecules to incorporate elemental tags for ICP-MS 
analysis. In our laboratory the reagent tris(trimethoxyphenyl)phosphonium (TMPP) 
has been used to tag various organic carboxylic acids to improve their ionisation 
and detection using ESI-MS®®. In addition, because the tag contained a 
phosphorus group this allowed the subsequent elemental specific detection of 
carboxylic acids using ICP-MS®^. Another chemical derivatisation method 
employed cyclic diethylenetriaminepentaacetic acid anhydride (cDTPA) for the 
chemical derivatisation of primary amines to allow the tagging of copper®^ and 
subsequent detection using LC-ICP-MS. 
2.1.3 Bifunctional Chelating Agents 
Bifunctional chelating agents (BFCAs) are a class of organic compounds that 
exhibit two different functions; reaction with a specific organic moiety and chelation 
with a metal. Traditionally BFCAs have been extensively used as metal chelators 
in the development of radiopharmaceuticals and contrast agents for magnetic 
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resonance imaging (MRI). In the former application tumour targeting compounds, 
such as monoclonal antibodies and receptor directed peptides, are conjugated 
using BFCAs to deliver radioactive metals such as "^ In and ®'Cu. Many 
bifunctional compounds have been synthesised to react with different organic 
moieties, though they have mostly been based on known chelators such as, 
ethylenediaminetetraacetic acid (EDTA), diethylenetriaminepentaacetic acid 
(DTPA), and 1,4,7,10-tetraazacyclododecane-A/,/V;/V",/V"-tetraacetic acid (DOTA). 
Two strategies commonly employed to label organic molecules are; 1) The metal 
is chelated to the BFCA prior to the reaction with the organic molecule e.g. Eu-
Isothiocyanate-benzyl-DTPA used in the AutoDELFIA labelling strategy^^. 2) The 
BFCA is allowed to react with the organic molecule, with the metal chelation 
following to produce a metal-BFCA-organic complex®® 
2.1.3.1 Derivatisation of Amino groups with cDTPA 
Acid anhydrides such as cDTPA react primarily with nucleophiles such as alcohols 
or amines to form esters or amides respectively. The reaction between a primary 
amine group on a peptide and cDTPA is an acylation reaction, where a hydrogen 
atom in the primary amine (peptide) is replaced by an acyl group (RCO, where R = 
an organic group) to form an amide bond shown in Figure 2-1 and the detailed 
mechanism for the reaction in Figure 2-2. 
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Figure 2-1 Reaction scheme for the derivatisation of a peptide using cDTPA. 
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Figure 2-2 Reaction mechanism for the derivatisation of a peptide using cDTPA. 
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2.2 Experimental 
The methods in the following section describe peptide derlvatisation using cDTPA 
and the subsequent optimisation of the reaction. In addition, the characterisation of 
the derivatlsation reaction using ESI-MS and LC-ESI-MS/MS is described, as well 
as, the method for peptide labelling with indium. 
2.2.1 Reagents and Standards 
Naphthylamine, bradykinin acetate, cyclic diethylenethaminepentaacetic anhydride 
(cDTPA), sodium bicarbonate, and sodium acetate were purchased from Sigma 
Aldrich, (Gilllngham, Dorset, UK). Dimethyl sulfoxide (DMSO), ammonium acetate, 
nitric acid (trace analysis grade), LC grade acetonitrile (ACN) and methanol were 
obtained from were purchased from Fisher Scientific UK Ltd, (Loughborough, 
Leicestershire UK). Ammonium bicarbonate was purchased from Fluka, Sigma 
Aldrich. (Gillingham, Dorset, UK). Distilled delonised water (DDW) 18.2 MQ, was 
obtained using an Elga Maxima water purifying system. Aristar grade Indium 
atomic spectroscopy standard was purchased from VWR International (Poole. 
Dorset, UK). 
2.2.2 Membrane Desolvation 
A major limitation of HPLC-ICP-MS is the low tolerance of the plasma for organic 
solvents or dissolved salts used in HPLC mobile phases. The ICP is intolerant to 
large amounts of either of these, so mobile phase selection must be carefully 
considered. The most critical consideration when coupling ICP-MS to HPLC is to 
maximise analyte transport but minimise solvent transport to the plasma. 
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The underlying problem is that organic solvents have a higher vapour pressure 
than water which leads to an increased solvent loading on the plasma®^. This 
reduces the stability of the plasma and also causes a change in the capacitance of 
the plasma resulting in a higher reflected power^. which results in the shut down 
of the power supply. Further problems are encountered with gradient elution®^ As 
the eluent composition changes (to an increased organic content in reversed 
phase chromatography) the nature of the plasma changes, meaning that the ion 
lens settings and nebuliser gas flows that gave an optimal signal at the start of a 
gradient may not be optimal at the end of an elution gradient. This results in 
varying sensitivity over a chromatographic run leading to sloping baselines, 
calibration and quantification problems. 
From previous studies in our laboratory by Cartwright a/.^ ® the most promising 
approach to remove the solvent vapour was to use a membrane desolvation 
device. A membrane desolvator used at the interface between the spray chamber 
and torch may be used to remove close to 100% of organic solvent39. Within a 
membrane desolvator, the sample vapour enters a heated membrane and a 
counter-current flow of sweep gas (usually argon) is used to remove solvent 
vapours that diffuse across the membrane. The theory is that the solvent 
molecules are so small that they diffuse through the membrane, whereas the 
larger analyte molecules are too large and are not removed by the membrane. The 
removal of the solvent vapour, and thus the sensitivity of the instrument, is 
dependent on optimising the sweep gas flow. 
52 
2.2.3 Instrumentation 
All LC analyses were performed using the Luna C18 (2) column (Phenomenex, 
Macclesfield. UK) for reversed phase LC-UV/vis. LC-ICP-MS and LC-ESI-MS-MS 
analysis. The mobile phase comprised of a binary system of: eluent A, water 
containing 0.05% formic acid (v/v); and eluent B, acetonitrile containing 0.05% 
(v/v) formic acid. The linear gradient employed started at 100% A, changing to 
67% A and 33% B over 20 minutes. The flow rate was 1 ml min"^ with an injection 
volume of 25 ^L . 
The LC system used for the UV/vis and UV/vis-ICP-MS analysis was a HP 1090 
liquid chromatograph (Agilent Technologies, Stockport, UK). Element specific 
detection was performed using quadrupole ICP-MS (VG PlasmaQuad 3, Thermo 
Elemental. Winsford, UK). The ICP-MS sample introduction system consisted of a 
1.0 ml min"^ microMist nebuliser and a cyclonic spray chamber both purchased 
from Glass Expansion, AUS. The LC outlet was connected to the ICP-MS 
nebuliser via 2 m of Teflon tubing (1/16" x ID 0.18mm). A membrane desolvator 
(Vestec Corporation. Texas, USA) was connected between the spray chamber 
(Nebuliser) and torch to remove organic solvents. The dry aerosol exiting the 
desolvator was then transferred to the ICP torch via 1 m of 0.25 in. i.d. Tygon 
tubing. Operating and data acquisition conditions are shown in Table 2 -1 . 
LC-UV/vis-ESI-MS analysis was performed by using a Waters 2695 Separation 
Module and Waters 2487 dual wavelength absorbance detector. ESI-MS was 
achieved in positive ion mode using a Micromass Quattro Ultima Pt. The LC outlet 
was connected to the ESI-MS and UV/vis detector by a 30 cm length of PEEK 
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tubing (1/16" x ID 0.25mm) connected in line with a flow splitter (Upchurch 
Scientific, Washington, USA), the flow of 1 ml min"^ from the LC column was split 
at a ratio of 1:9, where 0.1 ml min'^ was sent to the electrospray ionisation source 
and 0.9 ml min*^ to the UV/vis detector. Typical ESI-MS and ESI-MS-MS 
conditions are given in Table 2-2. 
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Table 2-1 Operating and data acquisition conditions for Quadrupole ICP-MS. 
ICP 
Nebuliser gas flow / L min"^ 1.2 
Auxiliary gas flow / L min"^ 0.8 
Coolant gas flow / L min'^ 14.0 
RF forward power / W 1350 
Nebuliser 1.0 ml min*^ Micromist 
Spray chamber 
Torch 
Jacketed quartz cyclonic (room temperature) 
Quartz fassel-type 
Interface 
Sampling cone Nickel, 1mm i.d. 
Skimmer cone Nickel, 0.7mm i.d. 
Time Resolved Analysis 
Masses monitored "^ In 
Dwell time / ms 10 
Channels per mass 5 
Membrane Desolvatlon 
Sweep gas Argon 
Desolvation gas flow / L min"^ 1.0 
Desolvation temperature / °C 80.0 
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Table 2-2 Operating conditions for ESI-MS and ESI-MS/MS. 
ESI-MS Potentials 
Capillary voltage / kV 3.5 
Cone voltage / V 0.8 
RF lens 1 / V 100 
Aperture / eV 0.5 
RF lens 2 / V 1.0 
Mul t ip l ier /V 650 
MS-MS Potentials 
Low mass resolution 1 19.0 
High mass resolution 1 17.0 
Ion energy / V 1.0 
Collision cell entrance / V 80.0 
Collision cell Argon Ibar 
Collision gradient 0.0 
Collision cell exit / V 50.0 
Low mass resolution 2 15.0 
High mass resolution 2 15.0 
Ion energy / V 1.0 
G a s 
Desolvation gas flow / Lhr*^ 452 
Cone gas f low/ Lhr'^ 40.0 
Temperatures 
Source temperature / °C 80.0 
Desolvation temperature / °C 150.0 
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2.2.4 Preparation of Solutions 
All buffer solutions were prepared gravimetrically, stored at room temperature and 
discarded a month after preparation. 0.1 M solutions of sodium bicarbonate and 
ammonium bicarbonate were adjusted to pH 8 using hydrochloric acid and 0.1 M 
solutions of sodium acetate and ammonium acetate were adjusted to pH 6 using 
acetic acid. pH was measured using a calibrated Jenway 3010 pH meter (Jenway, 
UK). Molecular sieves (Sigma Aldrich, Gillingham, Dorset) were used to prepare 
the anhydrous DMSO. All peptide stock solutions were prepared in sodium 
bicarbonate pH 8. The cDTPA was prepared in anhydrous DMSO so no 
inadvertent hydrolysis of cDTPA would occur, 
2.2.5 Derivatisation and Chelation with In^* 
Initial attempts to derivatise amines using the method of Marshall at a/.®® were 
unsuccessful, the method required the addition of 800 pL of sodium bicarbonate 
(100 mM) to 100 pL of naphthylamine (1 mM) and 100 pL of cDTPA (1 mM). The 
solution was then left to react at room temperature for 60 minutes after mixing. A 
possible explanation for the unsuccessful derivatisation could be due to the 
reaction proceeding in a highly aqueous environment, which would favour the 
hydrolysis of the anhydride over the acylation reaction of the anhydride. 
Subsequently, the original method for the reaction of cDTRA with proteins by 
Hnatowlch at al.^^ was modified and applied to peptide derivatisation. The modified 
method required the addition of 0.2 g of cDTPA (4.6 mM) in anhydrous DMSO to 
0.2 g of peptide (2.3 mM). finally 0.1 g of sodium bicarbonate solution (100 mM) 
adjusted to pH 8 was added, the solution was left to stand after mixing for 60 
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minutes at room temperature. Derivatised peptides were chelated with indium; the 
indium stock solution was prepared in 0.1 M sodium acetate at pH 6. For ICP-MS 
analysis, 0.1 g of the derivatised peptide sample was added to 0.1 g of indium (3.6 
mM) then a further 0.8 g of 0.1 M sodium acetate pH 6 was added and the solution 
was agitated and left at room temperature for 30 minutes. The sample was further 
diluted 100 fold prior to analysis. 
2.2.6 Optimisation of Derivatisation Reaction 
Factors that were considered when optimising the derivatisation reaction were: 
reaction time; molar ratio of cDTPA to peptide; and stability of the cDTPA reagent, 
while factors such as room temperature were not considered as the acylation and 
hydrolysis of anhydrides proceeds from 4°C to 37°C to completion"^. In addition, 
buffer and pH conditions were selected according to Paik a/.® .^ who concluded 
that the acylation reaction of the anhydrides is buffer and pH dependent, and 
suggested that derivatisation was more efficient at pH 8.2 using a 0.1 M 
bicarbonate buffer. The chromatographic separation time was reduced, by 
increasing the gradient elution to 100% eluent B over 10 minutes to allow for high 
throughput. UV/vis detection of 220nm was selected as this seemed to offer much 
more sensitive detection and small changes in derivatisation can be quantifled. 
Reaction times of 0 minutes to 90 minutes were selected as this was considered 
the time required for the reaction to progress to completion and adequate time for 
the hydrolysis of unreacted anhydride. Molar ratio of reagents is considered one of 
the most important factors in analytical studies as excess reagents have to 
removed or inactivated as not to interfere with analysis, conversely excess 
58 
reagents are typically required to improve derivatisation efficiencies. The stability 
of the cDTPA reagent was also observed due to the highly reactive nature of 
anhydrides in atmospheric and aqueous solutions. 
2.2.7 Mass Spectrometry Studies 
2.2.7.1 ESI-MS 
Soft ionisation methods such as ESI-MS have been at the forefront of proteomic 
research for the analysis of intact chemical species and for structural information. 
ESI-MS can be employed in several modes to gather various different information 
from a single sample, which can either be inserted directly into the ionisation 
source or can undergo some type of chromatography prior to the ionisation 
source. 
Scanning ESI-MS was used to confirm the masses of reaction products. The mass 
scan spectrum was obtained by ramping the amplitude of the direct current (dc) 
and radio frequency (rf) voltages while keeping rf/dc ratio constant over a required 
mass range. The sensitivity of scanning ESI-MS is therefore determined by the 
mass range, scan speed and resolution. 
Multiple reaction monitoring (MRM) ESI-MS or tandem MS, was used to generate 
structural information. MRM-ESI-MS is a highly specific method with very high 
sensitivity due to fragmentation being known prior to analysis. The mass analyser 
of a triple quadrupole instrument consists of two quadrup les separated by a 
collision cell. The first quadrupole is used to select a first ion (precursor) which is 
fragmented in the collision cell. This collision induced dissociation (CID) is 
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achieved by accelerating the ions in the presence of a collision gas such as argon 
or helium. The collision energy of the gas can be varied to allow different degrees 
of fragmentation. The resulting fragments (daughter ions) are then analysed by the 
second quadrupole. Typically ESI-MS-MS both quadrup les are operated in static 
mode to increase sensitivity. Molecular masses to be monitored during MRM were 
determined by positive ion mode infusion ESI-MS-MS, where the derivatised 
sample was infused at 0.1 ml m\n\ 
LC hyphenated with ESI-MS and ESI-MS/MS was used to characterise the 
products of the cDTPA derivatisation reaction. Derivatisation for ICP-MS was 
performed using sodium bicarbonate buffer, however, this was changed to 
ammonium bicarbonate for ESI-MS to prevent sodium adducts forming during the 
ionisation process and to improve ionisation of the sample in the electrospray 
source. 
2.2.7.2 LC-ICP-MS 
Gradient LC-ICP-MS was used to determine whether the chelation of cDTPA with 
In^* was successful. Research by Cartwright et a/.^ ® showed that 100% acetonitrile 
gradient elution can be run in conjunction with ICP-MS detection without having a 
detrimental effect on the plasma and signal by using a membrane desolvator. In 
addition, membrane desolvation has the advantage of removing many polyatomic 
ion interferences thereby enabling selective detection of elements such as 
phosphorus using quadrupole ICP-MS. 
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2.3 Results and Discussion 
2.3.1 Derivatisation of Peptides with cDTPA 
Bradykinin, a nine amino acid peptide chain was used has a principle test peptide, 
because the peptide contains no readily detectable heteroatom by ICP-MS. its 
physiological important role in vasodilation especially with contraction of non-
vascular smooth muscle, increase vascular permeability and associated effects in 
pain mechanisms. The amino acid sequence is Arg - Pro - Pro - Gly - Phe - Ser -
Pro - Phe - Arg and molecular weight of 1060.21 with an empirical formula 
C50H73N15O11. 
In order to test the efficacy of the derivatisation of bradykinin with cDTPA, 
preliminary studies were performed using LC-UV/Vis detection at 254 nm. 
Chromatograms of underivatised and derivatised peptide are shown in Figure 2-3. 
As can be seen, the underivatised bradykinin eluted at 9.8 minutes whereas two 
peaks, corresponding to the derivatised peptide, eluted at 14.6 and 14.8 minutes 
respectively. The presence of two separate peaks for the derivatised bradykinin 
may possibly be explained by the fact that the cDTPA reagent contains two 
functional groups; hence it is possible that the derivatisation reaction yielded more 
than one product, though confirmation using ESI-MS would be required to confirm 
the hypothesis. 
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Time / min 
Figure 2-3 UV/vis Chromatograms at 254nm of bradykinin (red) and cDTPA derivatised 
bradykinin (black) using gradient elution: A, bradykinin; B, cDTPA-bradyklnin. 
62 
2.3.2 Optimisation of Derivatisation Reaction 
The effect of reaction time on the efficiency of derivatisation is shown In Figure 2-
4a. It is apparent that there was no significant difference in reaction efficiency 
regardless of the length of time after the initial derivatisation that the samples were 
analysed. This data is summarised in Table 2-3, which shows that the reaction 
efficiency was > 94% over a period of 16 hours for the derivatisation reaction when 
the cDTPA reagent was dissolved. However, stability of the reagent did have a 
significant effect on the reaction efficiency (Figure 2-4b, Figure 2-4c, Table 2-3), 
with - 87% of bradykinin being derivatised when the cDTPA reagent was 2 hrs. old 
and falling to between 29 - 49% when using 4 hr. old cDTPA reagent. This is 
probably because the cDTPA, which is susceptible to hydrolysis, was hydrolysed 
by residual water in the 'dry' DMSO. It is apparent from Table 2-3 that provided 
derivatisation was performed immediately after preparation of the reagent, it was 
not necessary to increase the reaction time past 30 minutes 
Hence, the reaction time was reduced to 15 min (to allow for the hydrolysis of the 
unreacted cDTPA) and additional molecular sieves were used to 'dry' the DMSO. 
These improvements were implemented prior to optimisation of the molar ratio of 
cDTPA to bradykinin. The effect of the ratio of cDTPA to bradykinin is shown in 
Figure 2-5. The efficiency of the derivatisation reaction was observed to increase 
from 70% to >99% when the cDTPA:bradykinin molar ratios was increased from 
1:1, 2:1 and 5:1 respectively. The efficiency of derivatisation was calculated from 
integrated peak areas of bradykinin remaining after derivatisation compared to a 
bradykinin standard using HP chemstation software. Bradykinin and cDTPA-
bradykinin was identified as peak A and B respectively based on retention times. 
The change in retention time of the bradykinin peak in the 2:1 (red trace) sample 
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could be either due to the reproducibility of the manual injection or due to the 
amount of underivatised bradykinin associated with the sample respectively. 
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Figure 2-4 Chromatograms (UV/Vis at 220nm) of bradykinin derivatised with cDTPA obtained 
at intervals after the initial derivatisation and reagents prepared: a. 0 hrs; b, 2 hrs; c, 4 hrs 
prior to the derivatisation. Peaks identified as: A. bradykinin; and B, cDTPA-bradykinin 
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Table 2-3 Percentage peak area data of derivatised bradykinin remaining after optimisation 
of reaction time and stability of cDTPA reagent. 
Injection time after 
derivatisation / min 
Percentage of bradykinin derivatised after sample preparation 
0 hrs 2 hrs 4 hrs 
0 96.4 86.6 39.1 
15 96.5 89.3 29.6 
30 96.3 86.7 45.9 
60 96.4 87.6 48.7 
90 96.3 87.3 48.3 
16hrs 94.8 87.5 44.0 
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Figure 2-5 UV/vis chromatogram at 220nm of cDTPA derivatised bradykinin at molar ratios 
of 1:1, 2:1 and 5:1 of increasing cDTPA concentration respectively. Peaks identified as; A, 
bradykinin; and B, cDTPA-bradykinin. 
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2.3.3 Mass Spectrometry Studies 
The infusion mass spectnjm of the cDTPA derivatised bradykinin solution is shown 
in Figure 2-6. the sample was prepared using ammonium bicarbonate as the 
buffer in order to increase ionisation efficiency of the electrospray source. The ion 
lenses were tuned to m/z 1436 because this was the m/z of the cDTPA derivatised 
bradykinin, and the mass range was limited to 100-1500 m/z to increase the 
sensitivity because only products of derivatisation within this range were expected. 
2.3.3.1 Peptide Fragmentation 
A notation has been developed for indicating peptide fragments that arise from a 
tandem mass spectrum (Figure 2-6). Peptide fragment ions are indicated by a, b, 
or c if the charge is retained on the N-terminus and by x, y or z if the charge is 
maintained on the C-terminus. The subscript indicates the number of amino acid 
residues in the fragment. 
Fragmentation of bradykinin typically involves the loss of either the N-terminal or 
C-terminal arginine amino acid depending on the energy of collisions in the second 
quadrupole respectively. The collision energies were typical set to remove the C-
terminal arginine residue and this was additionally confirmed by the fragmentation 
of the arginine residue attached to the C-terminal during MRM studies as the N-
terminal attached cDTPA was not fragmented (Figure 2-8d). 
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h ^2 y2 ^ X , y , 2, 
Figure 2-6 Peptide fragmentation notation using the scheme of Roepstorff and Fohlman 
The mass spectrum shows that bradykinin-cDTPA and bradykinin were present 
along with fragments, formed during the ionisation process, of both the bradykinin-
cDTPA and/or bradykinin. To confirm the origin of the fragments it would be 
necessary to isolate the bradykinin-cDTPA complex from the unreacted 
components of the derivatisation process. However, it is probable that m/z 1280 
originated from [bradykinin-cDTPA]* minus an arginine residue and m/z 905 
formed from either [bradykinin-cDTPA]" minus a cDTPA-arginine or [bradykinin]* 
minus an arginine residue. There was no evidence in the mass spectrum that 
cDTPA formed a conjugate with two bradykinin moieties, as what seemed to be 
the case from Figure 2-3. Further investigations were performed using L C - E S I -
MS-MS to determine whether two bradykinins are derivatised by a single cDTPA 
reagent, with results shown in Figure 2-7. 
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Figure 2-7 Infusion molecular mass spectrum of cDTPA derivatised bradykinin in 
ammonium based buffers using positive ion mode ESI-MS (scan range m/z 100-1500). 
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Figure 2-8a shows the UV/vis chromatogram for derivatised bradykinin. The 
bradykinin-cDTPA complex eluted in two peaks at 13.5 and 14.8 minutes, peaks B 
and C respectively, while the underivatised bradykinin eluted at 10.3 minutes 
peaks A. These peaks were confirmed by analysis using ESI-MS (Figure 2-8b) as 
well as retention times of the respective bradykinin standard. In order to identify 
the peaks eluting at 13.5 and 14.8 minutes ESI-MS was used in MRM mode to 
monitor the transitions 1061>905 (Figure 2-8c) and 1436>1280 (Figure 2-8d). 
These MRM transitions were monitored because they were fragmented during 
infusion ESI-MS and are associated with the loss of arginine residue from 
bradykinin and bradykinin-cDTPA respectively. This confirmed the presence of a 
single peak due to bradykinin at 10.3 minutes and two peaks due to bradykinin-
cDTPA at 13.5 and 14.8 minutes. 
The formation of the extra peak during derivatisation in ammonium bicarbonate 
compared to the sodium bicarbonate buffer could be explained by the buffering 
environment containing extra N H / ions which could react/bind to the cDTPA 
molecule. In addition the peak splitting seen in Figure 2-4a, may have been 
caused by column degradation due to high concentrations of cDTPA and trivalent 
metal ions over a period of time. 
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Figure 2-8 Chromatograms of derivatised bradykinin in ammonium bicarbonate buffer: A, 
UV-vis chromatogram at 254nm; Total ion count using positive ion mode ESI-MS; C, MRM 
transition 1061>905 using positive ion mode ESI-MS-MS; D, MRM transition 1436>1280 
using positive ion mode ESI-MS-MS. Peaks identified as: A, bradykinin; B and C, cDTPA-
bradykinin. 
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2.3.4 Elemental Mass Spectrometry Studies 
Figure 2-9 shows a chromatogram of derivatised bradykinin with detection using 
ICP-MS at m/z 115. The chromatogram shows three resolved peaks which were 
A, excess In^ from the chelation step; B, excess cDTPA from derivatisation step 
chelated with In^*; and C. bradykinin tagged with In^*, The bradykinin-cDTPA-ln 
complex was detectable at a concentration of 2.3 pM of bradykinin, corresponding 
to an indium concentration of 260 ng ml'V The chromatogram showed the 
derivatisation and chelation at a 1:2:4 molar ratio of bradykinin: cDTPA: indium 
respectively. Increasing the amount of excess cDTPA improved the derivalisation 
efficiency, however, chromatographic resolution between cDTPA-indium and 
indium tagged bradykinin peaks was reduced. 
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Figure 2-9 Chromatogram of derivatised bradykinin chelated with indium using ICR-MS 
detection at m/z 115. A, uncomplexed ln^;B, cDTPA-ln; C, bradykinin-cDTPA-ln. 
74 
Conclusions 
LC-ICP-MS has been used for the detection of peptides after derivatisatlon with a 
bifunctional chelating agent and subsequent chelation with In^* metal. This allowed 
element specific detection to be performed on peptides, which are typically not 
amenable for detection by ICP-MS. The derivatisation reaction was optimised to 
less than 30 min, with a derivatisation efficiency of - 9 5 % at a molar ratio of 2:1 
cDTPA to bradykinin. However, there is scope for improvement such as the 
removal of unreacted reagents prior to analysis, the use in complex samples, 
which are both considered in chapter 4. and improvement in sensitivity of the 
technique. LC-ESI-MS/MS was used for the characterisation of the derivatisation 
reaction using multiple reaction monitoring, which suggested that only single 
derivatised cDTPA had been formed and not a multiple derlvatised cDTPA. 
However, switching buffers from sodium to ammonium bicarbonate resulted in an 
additional bradykinin-cDTPA conformer which complicated identification. Current 
work is progressing to show that the relative quantitation of peptides is achievable 
by LC-ICP-MS using a modified form of the isotope dilution equation. 
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CHAPTER 3 RELATIVE QUANTITATION OF PEPTIDES BY 
ISOTOPIC LABELLING 
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Chapter 3 
3. INTRODUCTION 
The relative quantitation of peptides by molecular mass spectrometry has been at 
the forefront of proteomic research, however, one problem is the accuracy and 
precision of the measured peptide ratio. Gygi et a / .^ quoted "The percentage error 
of the experimental technique was found to be excellent (±10%)." when 
commenting on the accuracy of the relative quantitation obtained by the metabolic 
labelling technique^^. The error arises not from the labelling strategy but from the 
method of detection, and it is well known that labelling strategies which use 
molecular mass spectrometry struggle to differentiate between small differences in 
peptide expression. 
In this chapter, we describe the relative quantitation of differentially isotopically 
labelled peptides using ICP-MS detection. Gravimetrically prepared peptide 
samples were derivatised with cyclic diethylenetriaminepentaacetic acid anhydride 
and chelated with either natural or enriched europium. The ^^^Eu/^^^Eu isotope 
ratio was measured using LC-ICP-MS and this was used to calculate relative 
peptide ratios. LC-ESI-MS-MS was used to confirm europium chelation and to 
compare relative quantitation between organic and inorganic MS. 
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3.1 Relative Quantitation by ICP-MS 
The approach used for relative quantitation using europium labelling is shown 
schematically in Figure 3-1. The strategy is based on relative quantitation 
techniques described in Chapter 1. Two peptide samples, of a standard sample 
(nx) and an unknown sample (ny) were derivatised with cDTPA and chelated with 
either natural Eu or enriched Eu respectively. Equal amounts of the labelled 
peptides were then combined and the resulting europium ratio (Rb) can be 
determined from the LC-ICP-MS chromatogram. 
3.1.1 Theory 
Consider the situation where two separate solutions, one containing a known 
amount of peptide labelled with natural Eu (n^) is mixed with another containing a 
known amount of peptide labelled with enriched ^^^Eu (ny). Equation 3-1 shows 
how the isotope amount ratio (R) of ^ " E U / ^ ^ ^ E U in the resultant solution can be 
expressed. 
^ o , „ Moles o f ' " E u Equation 3-1 R 
Moles of'^'Eu 
This is the basis for the isotope dilution equation that can be further expanded to 
the generic form shown in Equation 3-2. 
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Figure 3-1 A schematic representation of the tagging of peptides for the relative quantitation 
by LC-ICP-MS. 
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{n A ) + {n A ) 
Equation 3-2 R = ^ ^ 
(n B ) + (« B ) 
Where: n^  is the amount of peptide labelled with natural Europium; Hy is the 
amount of peptide labelled with enriched ^^^Eu; Ax is the atom fraction of natural 
^ " E U ; BX is the atom fraction of natural ^^^Eu; Ay is the atom fraction of enriched 
^ " E U ; By is the atom fraction of enriched ^^^Eu. The equation can be rearranged to 
Equation 3-3 and the relative amount of peptide in the two samples can be 
determined. 
Equation 3-3 ^ = 
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3.2 Isotope Dilution Mass Spectrometrv for Speciation 
The measurement of stable isotope ratios has been used for a wide variety of 
applications, including geochronology, food authenticity, isotope tracer studies, 
climate analysis and many others. Isotope dilution mass spectrometry (IDMS) is a 
quantitative technique used to determine the amount fractions of an element in a 
sample and can be applied to all elements with two or more isotopes. This is 
accomplished by the addition of an isotopically enriched spike containing an 
accurately known amount, wnth known atom fractions, of the element to be 
determined In the sample. The technique has been extensively reviewed with 
advantages and disadvantages discussed by Neumann et a/.^°° 
IDMS has a number of advantages over traditional external calibration techniques, 
provided that the following pre-requisites are met^ °V 
• more than one interference-free, stable isotope must be available for isotope 
ratio measurement; 
• an isotopically enriched analogue, or spike, of the analyte must be available; 
• complete equilibration between the spike and sample must be achieved; 
• the mass fraction and isotopic abundances of the natural and enriched 
elements must be well characterised; 
• the spike and sample must be chemically stable. 
3.2.1 Calculation of Isotope Amount Ratio 
A recent review by Clough et ai^^ discusses how IDMS has been applied to 
speciation studies by LC-ICP-MS. focussing on measurement parameters, data 
extraction and minimising uncertainty. Two approaches can be used to determine 
the isotope amount ratios resulting from two transient signals from an LC-ICP-MS 
chromalogram. namely peak integration and pseudo steady slate. 
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3.2.1.1 Peak Integration 
Both isotope specific peaks for the species of interest In the LC-ICP-MS 
chromatogram are integrated; from these Integrals the isotope amount ratio for 
that species can be determined. An advantage of using this approach is that the 
effect of spectral skew is minimised, (Figure 3-2) however, precision is lost 
because multiple injections are required to obtain a standard deviation on the 
measured ratio. 
3.2.1.2 Pseudo Steady-State 
The pseudo steady state approach for isotope amount ratio measurements 
assumes that the chromatogram is an undulating signal and that at the apex of the 
peak a pseudo steady state is achieved (Figure 3-3). In order to achieve the best 
precision and accuracy, only data-points during the pseudo steady state of each 
species (peak) for each isotope of a particular species in the chromatogram. are 
used and baseline signal subtracted. The isotope amount ratio is calculated using 
each corresponding data-point from the two peaks and subsequently corrected for 
mass bias effects. The advantage of this approach is that the precision Inherent in 
making Isotope ratio measurements using a sequential or simultaneous mass 
spectrometer is maintained, and It is possible to obtain an estimate of precision 
from a single peak. However, spectral skew must be minimised in order to obtain 
an accurate isotope amount ratios. 
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Figure 3-2 Schematic illustrating spectral skew for ^^Eu and ^^^Eu isotopes signals obtained 
by FI-ICP-MS: A, no spectral skew; B, minor isotopes signal shifted by 2 seconds. 
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Figure 3-3 Isotope amount ratios measured using the pseudo steady state approach. The 
isotope amount ratio is calculated by ratioing the ion signals for coincident pairs of data 
points over the peak maximum. 
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3.2.2 Mass Bias Correction 
In order to obtain accurate isotope (and hence peptide) ratios it is necessary to 
compensate for mass bias In the instrumentation. Quadrupole and sector field 
ICP-MS instruments transmit ions of different mass with different efficiencies 
predominantly due to space charge effects in the ion source and interface 
region^°^ resulting in a non uniform response and inaccurate isotope ratio 
measurements. In other words, if an elemental solution composed of two isotopes 
with an exactly 1:1 molar ratio is analysed using ICP-MS. an isotope amount ratio 
of 1:1 will not necessarily be observed. Mass bias depends upon mass and the 
type of mass spectrometer used, but generally tends to be greatest at low mass 
and decreases with increasing mass. Mass bias may have deleterious effects on 
the accuracy of Isotope amount ratio determinations, so a correction must always 
be made, either by bracketing the sample with a certified reference material, or by 
interpolation from the mass bias observed for an isotope pair of similar mass to the 
isotope pair under study^^^. 
The most convenient method for mass bias correction in speciatlon analysis using 
LC-ICP-MS is to spike the mobile phase with an internal standard or to add the 
internal standard post column and to monitor it continuously. Mass bias of the 
^^^Eu:^^^Eu isotope amount ratio was corrected by interpolation of the mass bias 
observed for the ^^Sm;^^^Sm isotope amount ratio using the Russell correction 
expresslon^**^ shown in Equation 3-4. which corrects for mass bias on the basis of 
the absolute mass of the isotope pairs. The addition of the samarium Internal 
standard was achieved by adding the solution post column via a low dead volume 
t-piece. The advantage of this approach is that the mass bias correction can be 
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performed by spiking the sample on-line with the correction standard and 
measuring this isotope amount ratio at the same time as the sample. Europium is 
an ideal element for isotope ratio measurements because it is only has two 
isotopes which are free from polyatomic and isobaric interferences, and mass bias 
corrections can easily be made using a samarium standard. 
131 Eu 
mes 
TTi 
cer J 
Equation 3-4: The Russell correction expression used for mass bias correction of the 
europium isotope ratio. 
Where: cor is the corrected isotope amount ratio, mes is the measured isotope 
amount ratio; cer is the certified isotope amount ratio and RAM is the relative 
atomic mass. 
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3.3 Experimental 
The methods in the following section describe europium labelling of cDTPA 
derivatised peptides for relative quantitation. In addition, the methodology was 
optimised for isotope ratio measurements, as well as, the characterisation of the 
europium chelated peptides using ESI-MS and ESI-MS/MS. 
3.3.1 Reagents and Standards 
Bradykinin acetate, substance P, cyclic diethylenetriaminepentaacetic anhydride 
(cDTPA). sodium bicarbonate, thfluoroacetic acid (TFA), and sodium acetate were 
purchased from Sigma Aldrich. (Poole, Dorset, UK). Dimethyl sulfoxide (DMSO), 
ammonium acetate, nitric acid (trace analysis grade), LC grade acetonitrile and 
methanol were obtained from Fisher Scientific UK Ltd, (Loughborough, 
Leicestershire UK). Ammonium bicarbonate was purchased from Fluka, Sigma 
Aldrich, (Poole, Dorset, UK). Distilled deionised water (DDW) 18.2 MO, was 
obtained using an Elga Maxima water purifying system. ^^^Eu-enriched europium 
(EU2O3 99.24% enriched) was purchased from CK Gas Products, (Hampshire, 
UK). A standard ICP-MS solution of natural europium was purchased from Alfa 
Aesar (Heysham, UK). 
3.3.2 Instrumentation 
All LC analyses were performed using the Luna C I 8 (2) column (Phenomenex, 
Macclesfield, UK) for reversed phase LC-UV/vis, LC-ICP-MS and LC-ESI-MS 
analysis. The mobile phase was a binary system of: eluent A, water containing 
0.05% formic acid (v/v); and eluent B, acetonitrile containing 0.05% (v/v) formic 
acid. Two gradient elution profiles were employed: (1) a linear gradient elution, 
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performed by increasing mobile phase B from 0% to 33% over 20 minutes; (2) a 
nonlinear gradient elution profile where mobile phase B was increased from 0% to 
15% over 5 min and to 18.75% over the next 15 minutes The flow rate was 1 mL 
min'^ with an injection volume of 25 ^L . The LC system used for the UV/vis and 
UV/vis-ICP-MS analysis was a HP 1090 liquid chromatograph (Agilent 
Technologies, Stockport, UK). Element specific detection was performed using 
quadrupole ICR-MS (VG PlasmaQuad 3, Thermo Elemental. Winsford. UK). The 
ICP-MS sample introduction system consisted of a 1.0 mL min'^ microMist 
nebuliser and a cyclonic spray chamber both purchased from Glass Expansion 
(AUS). A samarium internal standard was added post column through an applied 
biosystems LC pump (Foster city. USA) via a low dead volume t-piece (Fisher 
Scientific, Loughborough, UK), which combined the two flows to the nebuliser via a 
30 cm PEEK tubing (1/16" x ID 0.18mm). A membrane desolvator (Vestec 
Corporation, Texas, USA) was connected between the spray chamber (Nebuliser) 
and torch to remove organic solvents. The dry aerosol exiting the desolvator was 
then transferred to the ICP torch via 1 m of 0.25 in. i.d. Tygon tubing. Operating 
and data acquisition conditions are shown in Table 3-1. 
Clough et a/.^°^ previously determined the optimised quadrupole ICP-MS data 
acquisition settings for isotope amount ratio analysis using the pseudo steady 
state approach. The data acquisition settings were further corroborated by 
measuring isotope ratios of natural europium samples spiked with known amounts 
of enriched europium. The resulting isotope ratios, measured by flow injection ICP-
MS, were compared to theoretical isotope ratios. Spectral skew was minimised by 
setting the dwell time to 10 ms, which has the advantage of increasing the number 
of data points at the apex of the chromatographic peak, for pseudo steady state. 
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LC-UV/vis-ESI-MS analysis was performed using a Waters 2695 separation 
module and Waters 2487 dual wavelength absorbance detector. ESI-MS was 
achieved in positive ion mode using a Micromass Quattro Ultima Pt. The LC outlet 
was connected to the ESI-MS and UV/vis detector by a 30 cm length of PEEK 
tubing (1/16" x ID 0.25mm) connected in line with a flow splitter (Upchurch 
Scientific, Washington, USA), the flow of 1 mL min'^ from the LC column was split 
at a ratio of 1:9, where 0.1 mL min'^ was sent to the electrospray ionisation source 
and 0.9 mL min"^ to the UV/vis detector. Typical ESI-MS and ESI-MS-MS 
conditions are given in Table 3-2. 
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Table 3-1 Typical ICP-MS operating conditions for isotope ratio measurements. 
ICR 
Nebuliser gas flow / L min'^ 1.3 
Auxiliary gas flow / L min'^ 0.8 
Coolant gas flow / L min"^ 14.0 
RF forward power / W 1350 
Nebuliser 1.0 ml min'^ Micromist 
Spray chamber Jacketed quartz cyclonic (room temperature) 
Torch Quartz fassel-type 
Interface 
Sampling cone Nickel, 1mm i.d. 
Skimmer cone Nickel. 0.7mm i.d. 
Time Resolved Analysis 
Masses monitored ^^^Eu. ^^^Sm. ^^^Eu. ^^Sm 
Data Acquisition Peak Jump 
Dwell time / ms 10 
Channels per mass 5 
Membrane Desolvation 
Sweep gas Argon 
Desolvation gas flow / L min'^ 0.9 
Desolvation temperature / °C 80.0 
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Table 3-2 Typical ESI-MS operating conditions. 
ESI-MS Potential 
Capillary voltage / kV 4.0 
Cone voltage / V 1.0 
RF lens 1 / V 150 
Aperture / eV 1.0 
RF lens 2 / V 1.0 
Multiplier / V 650 
MS-MS Potential 
Low mass resolution 1 10.0 
High mass resolution 1 10.0 
Ion energy / V 2.0 
Collision cell entrance / V 80.0 
Collision cell Argon Ibar 
Collison gradient 0.0 
Collision cell exit / V 70.0 
Low mass resolution 2 12.0 
High mass resolution 2 12.0 
Ion energy / V 1.0 
Gas 
Desolvation gas flow / Lhr"^ 450 
Cone gas flow / Lhr"^ 40.0 
Temperature 
Source temperature / °C 100 
Desolvation temperature / °C 150 
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3.3.3 Derivatisation and EiP* Chelation 
3.3.3.1 Bradvkinin Derivatisation and Eu^" Chelation 
Using the optimised method for peptide derivatisation described in section 2.2.4, 
two bradykinin samples (23 pM, 0.2 g) were derivatised with cDTPA (46 pM, 0.2 
g), sodium bicarbonate pH 8 (0.1 M, 0.1 g) was added to give a final mass of 0.5 
g. The samples were the left to react for 15 min. either natural or enriched 
europium (36 pM, 0.1 g) was added to separate 0.1 g aliquots of the two 
derivatised peptide samples. Sodium acetate pH 6 (0.1 M, 0.8 g) was added to 
adjust the pH of the resulting solution for ICP-MS analysis. The samples were then 
left for 30 minutes to ensure complete chelation before analysis. Subsequently the 
two derivatised, chelated samples were mixed in the proportion of 1:1 (0.25 g). 
Varying bradykinin concentrations were derivatised with cDTPA (46 pM) and 
chelated with europium enriched (36 pM) for relative quantitation. Samples for 
ESI-MS analysis were prepared in ammonium bicarbonate pH 8 and ammonium 
acetate pH 6 buffers. However, concentrations of reagents were increased ten-fold 
for ESI-MS detection. 
3.3.3.2 Substance P and Peptide Mixture Derivatisation and Eu^^ Chelation 
Using the method described in section 3.3.3.1, substance P (23 pM) ,and a 
peptide mixture containing bradykinin (23 pM O.lg) and substance P (23 pM 0.1 
g), were derivatised with cDTPA (46 pM, 0.2 g ). A 0.1 g aliquot of the derivatised 
sample was chelated with either natural and enriched europium (36 pM, 0.1 g). 
Sodium acetate pH 6 (0.1 M, 0.8 g) was added to adjust the pH of the resulting 
solution for relative quantitation ICP-MS analysis. 
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3.3.4 Isotope Ratio Measurement by LC-ICP-MS 
Isotope ratio measurement conditions were optimised using several standards of 
natural europium spiked mih known amounts of enriched europium and measured 
using flow injection ICP-MS, with a samarium internal standard (66.5 nM) in the 
carrier stream. Various dwell times and channels per mass were used to measure 
the ^^Eu/^^^Eu isotope ratio with the previously described data extraction 
methods. Analysis of the data suggested that the pseudo-steady state approach, 
with a dwell time of 10-20 ms and 5 channels per mass, resulted in mass bias 
corrected Isotope amount ratios which were closest to the theoretical values of the 
gravimetrically prepared samples. In addition, a greater degree of precision was 
obtained using the pseudo steady approach compared to that obtained by peak 
integration. This was in agreement with previous findings^°®. 
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3.4 Results and Discussion 
3.4.1 Investigation of Derivatisation and Chelation using ESI-MS 
Figure 3-4 shows the infusion mass spectrum of natural europium chelated with 
derivatised bradykinin, (^^^Eu-cDTPA-bradykinin* m/z 1584 and ^ " E U - C D T P A -
bradykinin* m/z 1586), confirming the formation of these species. However, due to 
insufficient resolution the isotopic pattern for europium was not observed. The 
europium labelled bradykinin (m/z 1584) was further fragmented by collision 
induced dissociation to determine the molecular masses of possible daughter ions 
(m/z 905 and m/z 540) that could be subsequently monitored by MRM (multiple 
reaction monitoring). 
Further complementary LC-ESI-MS-MS yielded the chromatograms shown in 
Figure 3-5. Figure 3-5a shows the LC-ICP-MS chromatogram of bradykinin 
derivatised in sodium bicarbonate buffer. The derivatisation of bradykinin in 
ammonium bicarbonate and chelation with europium in ammonium acetate buffer 
yielded two peaks at 12.3 and 14.8 min respectively (Figure 3-5b, c and d) 
observed using gradient elution profile 1. Confirmation that these peaks were due 
to bradykinin-cDTPA-Eu was obtained provided by monitoring the MRM transition 
corresponding to 1584>905 (Figure 3-5c) and 1584>540 (Figure 3-5d). These 
transitions resulted from the loss of a cDTPA-Eu-arginine group and bradykinin 
from the bradykinin-cDTPA-Eu complex respectively. Additional monitoring of 
1061>905 (Figure 3-5d) confirmed that there was a separate peak associated with 
bradykinin. The presence of two eluted Eu-cDTPA-peptide complexes was the 
result of the initial derivatisation of the peptide with cDTPA; no additional Eu-
complexes were formed that were detected by ESI-MS analysis. In addition, 
Figure 3-5e shows the MRM transition corresponding to bradykinin fragmentation. 
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Figure 3-4 Infusion ESI-MS of the daughter ions of bradyklnin chelated with enriched 
europium. 
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Figure 3-5 Chromatograms of bradykinin derivatised with cDTPA and chelated with natural 
E u ^ : a. ICP-MS detection at m/z 151; b, ESI-MS total ion count; c, ESI-MS-MS MRM transition 
1584>904; d. ESI-MS-MS MRM transition 1584>540; e, ESI-MS-MS MRM transition 1061>905. 
Peaks identified as: A, free E u ^ ; B, cDTPA-Eu; C and D, Eu-cDTPA-bradykinin; and E, 
bradykinin. 
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3.4.2 Interference of Buffers 
The effect that using ammonium based buffers derivatisation with cDTPA can yield 
multiple by-products has been discussed in chapter 2. Figure 3-6 compares the 
LC-ICP-MS and LC-ESI-MS chromatograms of bradykinin derivatised in 
ammonium bicarbonate and chelated v\flth europium in ammonium acetate. The 
LC-ESI-MS trace results in the elution of bradykinin (D) and two bradykinin-
cDTPA-Eu (E and G) peaks at 9.2 min and 13.5 minutes respectively. However, 
the corresponding LC-ICP-MS yielded several peaks, these were identified as (A) 
free E u ^ , (F) cDTPA-Eu, (E and G) bradykinin-cDTPA-Eu, and (B and C) 
unknown Eu species. The origins of these unknown Eu species could possibly be 
due to the ammonium acetate buffer forming Eu-acetate complexes such as 
Eu(Ac)2* and Eu(Ac)3. 
3.4.3 Relative Quantitation by ESI-MS 
Relative quantitation of europium chelated peptides was attempted by LC-ESI-MS. 
However, mass resolution was not sufficient to distinguish between ^^^Eu and 
^^^Eu labelled bradykinin. To resolve the 2Da mass unit difference, a loss in 
sensitivity was observed, resulting in an ion signal which was not sufficient to 
accurately quantitate the derivatised chelated peptides. 
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Figure 3-6 iCP-MS m/z 151 (Black) and ESI-MS TIC (Red) chromatogram of derivatised 
bradykinin chelated with enriched europium in ammonium bicarbonate and ammonium 
acetate buffers using gradient elution profile 2: A, Free Eu^*; B and C, unknown Eu species: 
D, bradykinin; E, bradykinin-cDTPA-Eu: F, cDTPA-Eu; G, bradykinin-cDTPA-Eu. 
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3.4.4 Relative Quantitation using LC-ICP-MS 
Figure 3-7. Figure 3-8, and Figure 3-9 show chromatogram obtained for 
derivatised bradykinin, substance P and a mixture of both the peptides 
respectively. The chromatogram in Figure 3-7 shows three resolved peaks: free 
Eu^* at 2 min, a broad peak due to cDTPA-Eu^ at 11 min and bradykinin-cDTPA-
Eu^* at 14.8 minutes. The chromatogram in Figure 3-8 shows peaks due to free 
Eu^* at 2 min, cDTPA-Eu^* at 11 min and substance P-cDTPA-Eu^* at 18 minutes. 
Derivatised and Eu chelated substance P eluted in several unresolved peaks, 
possibly due to the methionine residues in the peptide forming disulphide bridges. 
No ESI-MS analysis was performed to identify whether a disulphide bridge was 
formed. The chromatogram in Figure 3-9 shovi/s a mixture of derivatised bradykinin 
and substance P with the peaks due to free Eu^* at 2 min, cDTPA-Eu^* at 11 min, 
bradykinin-cDTPA-Eu^* at 14.8 min and substance P-cDTPA-Eu^* at 18 minutes. 
Comparing the traces of derivatised substance P and the mixture of peptides an 
additional peak (E) was resolved in Figure 3-8. Though no ESI-MS data was 
obtained for this complex, it can be assumed that this was caused by the formation 
of bradykinin-cDTPA-substance P-Eu complex. This complex could be formed 
because the cDTPA molecule contains two anhydride reactive moieties. 
The increase in background counts for ^^^Eu and ^ " E U in the chromatograms is 
probably due to the incomplete elution of the free europium, the background 
subsides to normal levels once complete elution of europium species has 
occurred. Hydrolysed cDTPA was injected post analysis to remove any non-eluted 
of column. 
98 
^00000 
z. 
u 
— 
z 3 
o 
u 
c o 
25000 
'0 
Time (min) 
^5 20 
Figure 3-7 Multi-isotope ICP-MS chromatogram of derivatised bradykinin chelated with Eu 
using gradient elution profile 1. ^^^Eu black and ^^^Eu red. Resolved peaks. A, free Eu^*; B. 
cDTPA-Eu^*; and C, Bradykinin-cDTPA-Eu^*. 
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Figure 3-8 Multi-isotope ICP-MS chromatogram of derivatised substance P chelated with Eu 
using gradient elution profile 1. ^^^Eu black and ^^^Eu red. Resolved peaks; A, free Eu^*; B, 
cDTPA-Eu^'; and C. Substance P-cDTPA-Eu^*. 
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Figure 3-9 Multi-isotope ICP-MS chromatogram of a derivatised peptide mixture containing 
bradykinin and substance P chelated with Eu using gradient elution profile 1. ^^^Eu black 
and ^ " E U red. Resolved peaks; A, free Eu^*; B. cDTPA-Eu^; C, Bradykinin-cDTPA-Eu^*; D, 
Substance P-cDTPA-Eu^* and E, unknown resolved peak. 
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A pseudo steady-state approach was used to determine the isotope amount ratios 
from the multi-isotope chromatograms obtained by LC-ICP-MS. To obtain the best 
accuracy all co-incident data points were corrected by baseline subtraction. The 
obtained Eu ratio was mass bias corrected using the isotope amount ratio from the 
samarium internal standard. The ^"EU:^^^EU corrected ratio was then used to 
calculate the peptide ratio (nx/ny) using Equation 3-3. 
A comparison of the theoretical ratio, obtained from the gravimetric amount of the 
peptide, and the measured peptide ratios for bradykinin. substance P and a 
mixture of peptides Is shown in Table 3-3. As can be seen, the measured peptide 
ratios agreed extremely well with the theoretical ratios, with relative errors of 
between 0.1 and 2.8% so. in principle, small differences in peptide expression 
should be detectable. Additionally, the relative quantitation of substance P was 
hindered by the fact that this peptide forms disulphide bridges relatively easily so 
elutes as several peaks at approximately 17 min. The largest relative error in the 
peptide ratio occurred with the mixture of peptides (Figure 3-8). is most likely due 
to the formation of di-peptide Eu complexes. The relative errors were significantly 
larger on samples containing substance P; this was probably due to the inefficient 
chromatography and the possible disulphide bridge formation. The two peptide 
mixture also had large errors associated with the relative peptide amounts this is 
probably due to intermolecular binding associated with cDTPA. 
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Table 3-3 Relative quantitation of peptides comparing theoretical and measured peptide 
ratios. 
Sample Peptide Concentration 
(|iM) 
Theoretical 
Peptide 
ratio 
nx/ny 
Peptide 
ratio* 
nx/ny 
Measured 
± Relative ± Relative 
error (%) Expanded 
Uncertainty (%) 
1 Bradykinin 0.6 1.0016 1.0002 0.134 5.420 
2 Bradykinin 0.6 1.0016 1.0023 0.078 6.152 
3 Bradykinin 0.6 1.875 1.864 0.562 3.694 
4 Bradykinin 0.6 1.875 1.9015 1.411 5.746 
5 Substance P 0.7 1.021 1.037 1.925 3.438 
6 Substance P 0.7 1.021 1.032 1.492 9.800 
7 Bradykinin 0.6 1.029 1.010 1.897 13.034 
Substance P 0.7 1.027 1.002 2.470 15.432 
8 Bradykinin 0.6 1.029 1.057 2.790 7.392 
Substance P 0.7 1.027 1.003 2.322 8.586 
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The overall relative expanded uncertainty on the measured isotope amount ratio 
was determined by taking into account all the individual uncertainty components 
and combining them, after conversion to a standard uncertainty, using the 
spreadsheet method first described by Kragten et a/.^°^. Each spreadsheet 
constructed during this work was separately validated by manual calculation. In 
this particular case the relative expanded uncertainties were quite high up to 15%. 
This large uncertainty was associated with precision of the measured isotope 
ratios namely ^"EU:^^^EU and ^^Sm:''^^Sm. This could possibly be due to plasma 
instability. Previously, our experience of using isotope dilution analysis for the 
speciation of merthylmercury^°® it should be possible to reduce the standard 
uncertainty to less than 6% relative. 
To improve the precision on the measured isotope ratios multi-collector (MC)-ICP-
MS can be employed. Quadrupole ICR-MS measure isotopes sequentially 
therefore, any temporal fluctuations of the ion beam affects the accuracy and 
precision of the measured isotope amount ratio. Improvement in precision of the 
measured isotope amount ratio using MC-ICP-MS is because each isotope ion is 
measured simultaneously on appropriately spaced collectors. Thus, any 
fluctuations on one isotope ion will be equal on other isotope ions. 
The typical concentration of peptide that could be easily detected was 
approximately 0.6 pM. which equated to 23 pM of original peptide solution that 
was derivatised and chelated. The lowest concentration of peptide for which 
relative quantitation could be accurately performed, was 5 pM which equated to an 
absolute detection limit of 5 pmol injected on to the LC column. The lowest 
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detectable concentration of Eu-peptide complex was 100 nM which equated to an 
absolute amount of 0.1 pmol of peptide detected. While ICP-MS is capable of 
much lower detection limits, in this method the efficiency of the derivatisation 
reaction was the limiting factor. This was because, at low peptide concentrations, 
hydrolysis of cDTPA was favoured over the acylation reaction with cDTPA, 
resulting in lower derivatisation efficiency. 
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3.5 Conclusions 
The relative quantitation of peptides via the use of differential isotopic tagging has 
been achieved using LC-ICP-MS detection. Peptides were derivatised using cyclic 
diethylenetriaminepentaacetic anhydride and labelled with natural and enriched 
europium to differentiate between samples. This allowed ^^^Eu and ^^Eu detection 
of bradykinin and substance P. which are not amenable to detection by ICP-MS. 
The technique of derivatisation involving differential isotopic tagging, has 
expanded the scope of ICP-MS allowing the detection of proteins and peptides, 
rather than being restricted to the speciation of metallo-proteins or heteroatom 
containing proteins/peptides. This method has the potential for accurate relative 
and absolute quantitation of peptides, especially if a multicollector instrument Is 
used, which should result in a much better precision for the isotope ratio 
measurement. A number of challenges still need to be overcome to make this a 
viable approach, namely to improve detection limits, remove excess reagents and 
the relative quantitation of complex samples. 
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CHAPTER 4 INVESTIGATION OF NEW DERIVATISATION AGENTS 
AND TECHNIQUES 
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Chapter 4 
4. INTRODUCTION 
It has been shown in chapter 3 that ICP-MS can be used to relatively quantitate 
peptides with high accuracy and precision. However, the current technique of 
peptide derivatisation is limited to single peptide samples and cannot be directly 
compared to current methods, which are used to relatively quantitate hundreds to 
thousands of peptides. Hence, for the methodology developed to be comparable 
complex samples must be analysed with comparable accuracy and precision. 
In this chapter the derivatisation of complex peptide samples with various 
bifunctional chelating agents is described. The concept of solid phase analytical 
derivatisation^°® (SPAD) to improve relative quantitation is also introduced. The 
SPAD technique utilises a solid phase support for derivatisation and removal of 
excess reagents, and derivatised peptides can be selectively extracts for LC-ICP-
MS. 
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4.1 Derivatisation of Complex Samples 
In previous studies using cDTPA for derivatisation it was determined that the 
reagent was unsuitable for reaction v^th complex samples because the resulting 
derivatisation reaction could yield multiple unwanted by-products^°®. These by-
products were easily formed because cDTPA contains two reactive anhydride 
moieties. This is a significant problem because the majority of proteomic samples 
will contain a large number of peptides. The formation of unwanted side products 
with cDTPA has been demonstrated with insulin by Maisano et a/.^ °®. Figure 4-1 
shows the potential by-products that can be formed from the derivatisation 
reaction of peptides with cDTPA. An intermediate (A) is formed when the primary 
amine of the peptide is derivatised by the first anhydride group, and. depending on 
how the second anhydride group reacts, three different derivatised peptide 
complexes can occur: complex B, a single derivatised peptide with the second 
anhydride group hydrolysed; complex C, intermolecular derivatisation, a cDTPA 
complex that has been derivatised with another peptide; and complex D, 
intramolecular derivatisation, a cDTPA complex that has derivatised an amine 
group within the original peptide. 
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Figure 4-1 A schematic representation of the potential by-products that can be formed from 
the derivatisation reaction between cDTPA and peptide. Figure modified from Bennett ef 
al. 110 
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4.1.1 Monoreactive Bifunctional Chelating Agents 
In order to prevent the formation of multiple by-products, monoreactive bifunctional 
chelating agents have been synthesised. This class of compounds contain only 
one reactive moiety, thereby eliminating the possibility of multiple by-product 
formation. Figure 4-2 shows structures of the bifunctional chelating agents that 
have been considered for peptide derivatisation. These BFCAs are based on 
various chelating agents such as ethylenediaminetetraacetic acid (EDTA). 
nitrilotriacetic acid (NTA). diethylenetriaminetetraacetic acid (DTTA), and 
diethylenetriaminepentaacetic acid (DTPA), with the most popular being DTTA and 
DTPA. These modern BCFAs have also been synthesised with various reactive 
moieties such as those specifically designed to react with amines i.e. 
isothiocyanate. carbonates, anhydrides or designed to react with specific 
functional groups such as, thiols e-terminal lysines and amines, these reaction 
mechanisms and conjugations have been extensively discussed^^V 
111 
C N N 
(A) 
N O 
HOOC 
N 
Bu-tOOC-
Bu-tOOC 
(B) 
-\ / \ /—COOBu-t 
N N 
J "^COOBu- t 
COOH 
HOOC COOH 
SCN-
^ C O O H 
•COOH 
/ — C O O H 
N 
COOH 
Figure 4-2 Chemical structures of (A) cOTPA, (B) Monoreactive DTPA. (C) Monoreactive 
maleimide DTPA (D) Isothiocynanate-benzyl-EDTA. 
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4.1.1.1 Monoreactive Diethvlenetriaminepentaacetic Acid 
Monoreactive Diethylenetrlaminepentaacetic Acid (mDTPA) structure B In Figure 
4-2 has been synthesised by Arano et alV^ for use in the synthesis of 
radioisotopic labelled antibodies by solid phase. A major advantage of mDTPA is 
that it is soluble in a variety of solvents, making it useful in either solution or solid 
phase derivatisation. However, the major disadvantage is that mDTPA is not 
commercially available and, according to Arano (personal communication), the 
synthesis is difficult and could take months to complete. 
4.1.1.2 Maleimide Diethvlenetriaminepentaacetic Acid 
Maleimide diethylenetriaminepentaacetic acid (MDTPA) was synthesised by Arano 
et alV^ to overcome the problems caused by inter- and intramolecular cross 
linking with cDTPA derivatisation. MDTPA (Figure 4-2C) contains a maleimide 
group which reacts readily with thiol containing molecules (e.g. proteins and 
peptides). The original MDTPA synthesis took several steps, though recently 
Lattuada et a/.""* published a simple synthetic route yielding gram quantities. 
4.1.1.3 Isothiocvanate-Benzvl-ethvlenediaminetetraacetic Acid 
Isothiocyanate-benzyl-ethylenediaminetetraacetic acid (SCN-Bz-EDTA) (Figure 4-
2D) was synthesised by Meares et alV^ for the purpose of attaching various metal 
ions to monoclonal antibodies. The isothiocyanate group reacts with nucleophiles 
such as amines, sulfhydryls and the phenolate ion of tyrosine side chains. 
However, the only stable product of the reaction is with primary amine groups^^V 
Therefore, isothiocyanate compounds are almost entirely selective for modifying e-
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terminal and N-terminal amines in proteins, or primary amines in other 
molecules"®. 
4.1,2 Complex Samples 
When considering the analysis of 'real' samples the analytical method will only be 
as good as the sample preparation employed. For example, the analysis of sea 
water by ICP-MS often requires some form of sample preparation such as the 
removal of matrix components and interfering ions, or detrimental effects on 
chromatography, detection, accuracy and precision can be observed. Most 
proteomic methods isolate the analytes of interest to reduce sample complexity. 
For example, the ICAT^® method uses biotin avidin chromatography to isolate and 
preconcentrate derivatised peptides and remove excess reagent and 
underivatised peptides. 
4.1.2.1 Solid Phase Analytical Derivatisation 
A major requirement of derivatisation reactions is that the reaction must work at a 
low analyte concentration. However, at low levels, reaction kinetics are reduced 
resulting in a lower derivatisation efficiency. Other disadvantages of solution phase 
derivatisation are: 
• Many reagents are unstable. 
• Yields multiple by-products. 
• The analyte is typically diluted by the addition of reagents. 
• Reaction rates in general are poor. 
• Excess reagent must always be removed or deactivated. 
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One of the advantages of solid phase analytical derivatisation (SPAD) is that it 
improves efficiency at low concentrations so it seems an attractive alternative 
derivatisation method^^^. The SPAD technique typically uses solid phase 
extraction (SPE) tips for sample preparation, derivatisation and elution. The basic 
strategy for SPAD, is that the sample is loaded onto the solid phase sorbent, and 
derivatised. followed by elution in gradient fractions. 
Several reviews and publications^^®' have been presented on solid phase 
analytical derivatisation. Keough et a/.^ ®^ reported the solid phase sulfonation of 
tryptic peptides absorbed onto Ci8 pZiptip™. The technique involved the sample 
clean up of the tryptic peptides, which was sorbed on the Cis zip tip and then 
sulphonated prior to MALDI-MS analysis. 
Sample Isolation 
Solid phase sorbents have previously been used to isolate and preconcentrate 
analytes of interest. Once the sample is loaded onto the sorbent. matrix 
components can be removed from the SPE cartridge using mild eluents. The 
advantage of this approach is that the analyte is isolated in a narrow band on the 
solid phase tip. Preconcentration of the analyte can also result in a two-fold 
improvement in derivatisation efficiency. First, the analyte is isolated in a defined 
volume by the chromatofocusing effect, resulting in the 'local' concentration being 
higher than in solution. Another effect of preconcentration is that the load to elution 
volume ratio can be varied, thus determining the level of preconcentration^^^. 
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Reagent Loading 
Reagents used for solid phase derivatisation should be chosen to yield a rapid 
reaction, produce no by-products, not interfere with subsequent analysis and 
should be soluble in a weak loading solvent. The latter Is the most important 
aspect of SPAD; if a strong loading solvent is used the reagent is not likely to be 
retained on the solid phase along with the analytes. 
DenVa//sa//on 
As with solution phase derivatisation. reaction time, temperature and pH can all be 
optimised to improve reaction efficiency. 
Elution 
Derivatised analytes can be selectively eluted from the solid phase by increasing 
the eluent strength in a stepwise gradient. In addition, excess reagent can be used 
for derivatisation because unreacted reagent can be removed or isolated from 
analytes prior to analysis. Elution of the sample in this manner can be 
advantageous to the subsequent HPLC separation, as the complex sample is 
fractionated prior to LC-UVA/is and LC-ICP-MS. 
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4.2 Experimental 
The methods in the following section describe the derivatisation of cDTPA and 
SCN-Bz-EDTA to peptide(s) for qualitative and relative quantitation analysis. In 
addition, the derivatisation methodology vi/as further developed to improve 
derivatisation efficiency and complex sample handling with the use of SPAD. 
4.2. t Reagents and Standards 
Bradykinin acetate, HPLC peptide mix, cyclic diethylenetriaminepentaacetic 
anhydride (cDTPA). sodium bicarbonate, sodium acetate, sodium carbonate, 
ammonium carbonate and thfluoroacetic acid (TFA) (reagent grade) were 
purchased from Sigma Aldrich, (Poole, Dorset. UK). Isothiocyanate-benzyl-EDTA 
was purchased from Dojindo Laboratories (Kumamoto, Japan). Dimethyl sulfoxide 
(DMSO), ammonium acetate, nitric acid (trace analysis grade). LC grade 
acetonitrile and methanol were obtained from Fisher Scientific UK Ltd, 
(Loughborough, Leicestershire, UK). Ammonium bicarbonate was purchased from 
Fluka, Sigma Aldrich. (Poole, Dorset, UK). Distilled deionised water (DDW) 18.2 
MQ, was obtained using an Elga Maxima water purifying system. ^^^Eu-enriched 
europium ( E U 2 O 3 99.24% enriched) was purchased from CK Gas Products, 
(Hampshire, UK). A standard ICP-MS solution of natural europium was purchased 
from Alfa Aesar (Heysham, UK). Aristar grade indium atomic spectroscopy 
standard was purchased from VWR International (Poole, Dorset, UK). 
4.2.2 Instrumentation 
All LC analyses were performed using the Luna C18 (2) column (Phenomenex, 
Macclesfield, UK) for reversed phase LC-UV/vis and LC-ICP-MS analysis. The 
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mobile phase was a binary system of: eluent A, water containing 0.05% formic 
acid (v/v); and eluent B, acetonitrile containing 0.05% (v/v) formic acid. Various 
gradients were used in this chapter of research therefore the LC gradient profiles 
will be mentioned with in the appropriate sections. The flow rate was 1 ml min'^ 
with an injection volume of 25 |iL for all analyses. 
The LC system used for the UV/vis and UV/vis-ICP-MS analysis was a HP 1090 
liquid chromatograph (Agilent Technologies, Stockport, UK). Element specific 
detection was performed using quadrupole ICR-MS (VG PlasmaQuad 3, Thermo 
Elemental, Winsford, UK). The ICP-MS sample introduction system consisted of a 
1.0 ml min'^ microMist nebuliser and a cyclonic spray chamber both purchased 
from Glass Expansion (AUS). The LC outlet was connected to the ICP-MS 
nebuliser via 2 m of Teflon tubing (1/16" x ID 0.18mm). A membrane desolvator 
(Vestec Corporation, Texas, USA) was connected between the spray chamber 
(Nebuliser) and torch to remove organic solvents. The dry aerosol exiting the 
desolvator was then transferred to the ICP torch via 1 m of 0.25 in. i.d. tygon 
tubing. Operating and data acquisition conditions are shown In Table 4 -1 . 
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Table 4-1 Operating and data acquisition conditions for Quadrupole ICP-MS. 
ICP 
Nebuliser gas flow / L min'^ 1.3 
Auxiliary gas flow / L min'^ 0.8 
Coolant gas flow / L min"^ 14.0 
RF forward power / W 1350 
Nebuliser 1.0 ml min'^ Micromist 
Spray chamber Jacketed quartz cyclonic (room temperature) 
Torch Quartz fassel-type 
Interface 
Sampling cone Nickel, 1mm i.d. 
Skimmer cone Nickel, 0.7mm i.d. 
Time Resolved Analysis 
Masses monitored ^^^Inor^^^Eu, ^ " S m . ^"EU , ^^Sm 
Data Acquisition Peak Jump 
Dwell time / ms 10 
Channels per mass 5 
Membrane Desolvation 
Sweep gas Argon 
Desolvation gas flow / L min"^ 0.9 
Desolvation temperature / °C 80.0 
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4.2.3 cDTPA Derivatisation 
The HPLC peptide mixture contained five peptides Giy-Tyr, Val-Tyr-Val, Leu-
enkephalin, Met-enkephalin and angiotensin II at approximately 0.5mg per 
peptide. The peptide mixture was derivatised according to the modified method in 
section 2.2.4, 0.2 g of the peptide mixture sample (0.2 mM) was derivatised with 
0.2 g of cDTPA (0.4 mM) in anhydrous DMSO, finally 0.1 g of sodium bicarbonate 
solution (100 mM) adjusted to pH 8 was added, the solution was left to stand, after 
mixing, for 30 min. at room temperature. An aliquot of the derivatised peptide was 
analysed by LC-UV/vis prior to LC-ICP-MS. The derivatised peptide mix was 
chelated with Eu^* for ICR-MS analysis by adding 0.1 g of a 60 pM Eu^* solution in 
0.1 M sodium acetate (pH 6) to 0.1 g of the derivatised peptide solution, then a 
further 9.8 g of 0.1 M sodium acetate pH 6 was added and the solution was 
agitated and left at room temperature for 30 minutes prior to analysis. The gradient 
chromatography for these samples was a step gradient, starting with 0% eluent B 
from 0-5 minutes with a gradient to 50% eluent B over 20 minutes, and then up to 
100% the over next 5 minutes. 
4.2.4 Isothiocvanate-Benzyl-EDTA Derivatisation 
SCN-Bz-EDTA peptide reaction shown in Figure 4-3 involves nucleophilic attack 
on the central, electrophilic carbon of the isothiocyanate group. The resulting 
electron shift and proton loss creates a thiourea linkage between the 
isothiocyanate-containing compound and the amine, with no leaving group 
involved^°^. The SCN-Bz-EDTA compound is monoreactive and reacts with the 
target amine between pH 8-9 where the amine groups are mainly unprotonated. 
Reaction times vary from 4 to 24 hrs at 4°C. Various buffers can be selected for 
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this reaction such as sodium carbonate, sodium phosphate and borate buffered 
saline. 
s s 
R-NH, + R' —N=^ ^ R ' — N - L N - R 
H H 
Amine Isothiocyanate Isothiourea Bond 
Compound Compound 
Figure 4-3 Reaction scheme for the derivatisation of peptides using SCN-Bz-EDTA 
The derivatisation reaction was performed in a similar manner to the cDTPA 
derivatisation method (section 2.2.3) in terms of concentrations and molar excess 
of reagents. All reagents were prepared in 0.1 M sodium carbonate pH adjusted to 
8 using hydrochloric acid. 0.2 g SCN-Bz-EDTA (0.4 mM) was added to 0.2 g 
peptide sample (0.2 mM), and a further 0.1 g of 0.1 M sodium carbonate was 
added to give a final mass of 0.5 g. 
The derivatisation was optimised for three different reaction factors: time; pH and 
temperature. The chromatographic separation for the optimisation experiments 
was a step gradient by increasing eluent B to 100% over 20 minutes and then held 
isocratically at 100% B for a further 10 minutes. 
The chelation of metals, europium and indium, was performed in 0.1 M ammonium 
ci trate"^ adjusted to pH 6 using citric acid. A 0.1 g aliquot of the SCN-Bz-EDTA 
derivatised peptide sample was added to 0.1 g of trivalent metal (320 pM), the pH 
of the resulting solution was adjusted to pH 6 using 9.8 g of 0.1 M ammonium 
citrate. 
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4.2.5 So//'d Phase Extraction Peptide Recovery 
Disposable solid phase extraction (SPE) cartridges Ci8 (octadecyl. 18% carbon) 
columns containing 500 mg of sorbent (40pm, 60A), with a column volume of 2.8 
ml were obtained from Varian (Harbour City, CA, USA) and used for SPE and 
SPAD experiments. The peptide mix was dissolved in 0.1 M sodium carbonate 
buffer to give a total peptide concentration of 0.05 mg/ml. The peptide 
concentration was sufficient to be detected by the LC-UV/vis analysis but not 
overload the SPE column. 
To determine if the individual peptides in the HPLC peptide could be separated by 
SPE the following procedure was employed. The SPE procedure was modified 
from a method by Herraiz at a/.^^°. The Ci8 sorbent was conditioned prior to 
peptide loading by passing successively, ImL of methanol. 1 mL of Milli-Q water 
and 1 mL 0 . 1 % TFA. Once the sorbent was conditioned, peptide loading and SPE 
were performed by passing a 1 mL portion of the peptide mix through the SPE 
column at a flow rate of 1 mL/min maintained using a peristaltic pump. The 
peptides retained on the SPE column were washed with 1 mL of 0 . 1 % TFA. 
Subsequently, peptides were eluted in fractions via a stepwise ACN gradient. ACN 
fractions were 25% ACN, 50% ACN, 75% ACN, and 100% ACN eluted In this 
order through the SPE column. Each collected fraction was individually analysed 
using LC-UV/vls. The HPLC gradient elution profile for these analysis was a linear 
gradient over 10 minutes from 0% - 100% eluent B. The peak area of each peak 
arising from each SPE elution fraction was compared to peak areas of a non SPE 
extracted reference sample. 
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4.2.6 So/ /d Phase Extraction of SCN-Bz-EDTA Derivatised Peptides 
Subsequently, SCN-Bz-EDTA derivatised peptide(s) were solid phase extracted 
using the method described in section 4.2.5. The peptide(s) sample were 
derivatised according to the method in section 4.2.4 but without metal chelation. 
This procedure was investigated to determine whether SPE can isolate metal 
labelled peptides from excess reagent used in the derivatisation and chelation 
steps. In addition, three more eluent fractions were included these included 0 . 1 % 
TFA in 5%, 10% and 15% ACN to remove any excess metal from the chelation 
reaction. For purposes of high through-put LC analysis time was reduced to 15 
min per sample by increasing the gradient to 100% ACN over 10 min and holding 
isocratically for a further 5 min. 
4.2.7 So/ /d Phase Analytical Derivatisation 
To achieve SPAD, additional steps were added to the SPE methodology (section 
4.2.4). 1 mL of bifunctional chelating agent was passed through the column after 
the 0 . 1 % TFA peptide wash step, followed by 1 ml of trivalent metal addition. 
Figure 4-4 shows the apparatus required for SPAD. 
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Table 4-2 Comparison of SPE and SPAD methods. 
Solid Phase 
Extraction 
Solid Phase Analytical 
Derivatisation 
Column conditioning 
Sample loading 
Sample wash 
Derivatisation 
Chelation 
Elution 
1ml MeOH. 2ml0.1%ofTFA 
1ml Peptide(s) in buffer 
0.1% of TFA 
N/A ImlBFCA 
N/A 1 ml trivalent metal 
1ml of 0.1% TFA in 0-100% ACN 
Sol id p h a s e extract ion tip 
Water bath {mainta ined at ZJ^C) 
Per is ta l t i c p u m p tubing (l .d. 3.9) 
T 
Per is ta l t i c p u m p 
Figure 4-4 A schematic representation to show the apparatus required for solid phase 
analytical derivatisation 
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4.3 Results and Discussion 
4.3.1 cDTPA Derivatisation of Complex Samples 
The UV/vis chromatogram in Figure 4-5 shows both an underivatised and cDTPA 
derivatised peptide mix. The peptide mix contained five peptides, labelled A-E 
(Figure 4-5 red trace). When the peptide mix was derivatised, more than the 
expected number of derivatised products resulted (Figure 4-5 black trace). 
Typically, derivatisation of five peptides should result in five derivatised products; 
however, because the cDTPA reagent contains two reactive groups, complexes 
described in Figure 4-1 can be formed, resulting in extra peaks. The formation of 
the extra by-products would result in inaccurate relative quantitation because it is 
impossible to predict how much of each peptide would be derivatised in these 
additional by-products. 
The LC-ICP-MS chromatogram in Figure 4-6 shows the result of chelation of 
natural europium to the cDTPA derivatised peptide mix. The chromatogram shows 
five resolved Eu peaks possibly representing the singly derivalised peptides 
(Figure 4-6 A-E). A comparison of the respective UV/vis and ICP-MS 
chromatograms, suggests that intramolecular and intermolecular cDTPA species 
cannot chelate with trivalent metals, possibly due to the reduced number of co-
ordination sites available for chelation. II was concluded that new reagents such 
as monoreactive BFCA would have to be evaluated if the relative quantitation of 
complex samples was to be achieved. 
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Figure 4-5 LC-UV-vis chromatograms, with detection at 220nm, of underivatised (black) and 
derivatised (red) peptide mix using cDTPA. Original peptides are labelled A-E. 
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Figure 4-6 LC-ICP-MS chromatograms at m/z 153 of cDTPA derivatised peptide mix with Eu 
natural chelation. Peaks A-E represent Eu labelled peptides from peptide mixture. 
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4.3.2 SCN-Bz-EDTA Derivatisation 
The derivatisation reaction between peptides and SCN-benzyl-EDTA was 
optimised for reaction time, temperature and pH. Figure 4-7 to 4-10 show the 
UV/vis chromatograms of optimised derivatised samples of bradykinin and the 
HPLC peptide mixture respectively. The factors and levels used for the 
optimisation were: time, 2 and 24 hours; temperature, 4°C and 37**C; and sodium 
carbonate buffer, pH 8 and pH 9 respectively. Derivatisation efficiency was 
calculated by comparing the peak area of the underivatised peptide(s) to the 
standard HPLC peptide mixture and a bradykinin sample respectively. Figure 4-7 
and Figure 4-8 shows the derivatisation of bradykinin with SCN-Bz-EDTA after a 
reaction time of 2 and 24 hours respectively. The eluted peaks were identified as 
A, bradykinin, B, SCN-Bz-EDTA-Bradykinin, C, SCN-Bz-EDTA and D, SCN-Bz-
EDTA by-products, from the respective retention times. From chromatograms 
Figure 4-7a and 4-7b it is apparent that the derivatisation efficiency was affected 
by reaction temperature, increasing temperature from 4°C to 37°C improved 
derivatisation efficiency from 4% to 55%. Increasing derivatisation reaction time 
from 2 to 24 hours (Figure 4-7a and Figure 4-8a), further increased derivatisation 
efficiency by 15%. Changing buffer pH from 8 to 9 resulted in no significant 
increase or decrease in derivatisation efficiency. 
It was noted that the SCN-Bz-EDTA reagent was unstable in solution over a longer 
reaction t ime and at higher reaction temperatures. This instability is well 
documented for reagents containing isothiocyanates and isocyanates; this 
instability results in the breakdown of the isothiocyanate reagent into several 
species (labelled D in Figure 4-8b and 4-8d). However, molecular mass 
spectrometry would be required to identify whether these peaks are products of 
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the SCN-Bz-EDTA or bradykinin-SCN-Bz-EDTA. Figure 4-9 and Figure 4-10 
shows the derivatisation of a peptide mixture. Peaks A-E was identified as 
underivatised peptides, based on the respective retention times from standards; F, 
SCN-Bz-EDTA; and G, SCN-Bz-EDTA by-products, and peaks 1-5 were assumed 
to be derivatised peptides. Derivatised and underivatised peptides were 
determined on retention times and based on the disappearance of peptides and 
SCN-Bz-EDTA derivatisation reagent (Figure 4-10b and Figure 4-10d). The 
chromatograms showed that the optimal derivatisation condition was 24hrs, In pH 
9 buffer at a reaction temperature of 37°C. However, when using these 
derivatisation conditions a greater amount of SCN-Bz-EDTA by-products were 
formed. To distinguish between peptide-SCN-Bz-EDTA and SCN-Bz-EDTA by-
products would require LC-ESI-MS confirmation. Further complimentary LC-ICP-
MS data should also confirm the number of derivatised peaks and whether 
derivatisation was successful. 
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Figure 4-7 HPLC chromatograms, with UV/vis detection at 220nm, of bradykinin derivatised 
(2hrs) with SCN-Bz-EDTA: A, Bradykinin; B. SCN-Bz-EDTA-Bradykinin; C, underivatised 
SCN-Bz-EDTA; D. SCN-Bz-EDTA by-products. 
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Figure 4-8 HPLC chromatograms, with UV/vis detection at 220nm of bradykinin derivatised 
(24hrs) with SCN-Bz-EDTA: A, Bradykinin; B. SCN-Bz-EDTA-Bradykinin; C. underivatised 
SCN-Bz-EDTA; D. SCN-Bz-EDTA by-products. 
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Figure 4-9 HPLC chromatograms, with UV/vis detection at 220nm, of the HPLC peptide mix 
derivatised (2hrs} with SCN-Bz-EDTA. Underivatised peptides: A; B; C; D; E. Oerivatised 
peptides: 1; 2; 3; 4; 5 in the same order. F, SCN-Bz-EDTA; G, SCN-Bz-EDTA by-products 
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Figure 4-10 H P L C chromatograms. with UV/vis detection at 220nm, of the peptide mix 
derivatised (24hrs) with S C N - B z - E D T A . Underivatised peptides: A; B; C ; D; E . Derivatised 
peptides: 1; 2; 3; 4; 5 in the s a m e order. F, S C N - B z - E D T A ; G , S C N - B z - E D T A by-products 
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4.3.2.1 LC-ICP-MS of SCN-Bz-EDTA Derivatised Peptides 
The procedure to chelate indium with derivatised SCN-Bz-EDTA complexes, 
developed by Meares et al.^^^ recommended using 0.1 M ammonium citrate buffer 
adjusted to pH 6 using citric acid. Figure 4-11 shows the chelation of indium to 
SCN-Bz-EDTA in ammonium citrate and sodium acetate pH 6 (Figure 4-11a and 
Figure 4-11c) respectively. Previously, when chelating hydrolysed cDTPA, only 
two chromatographic peaks would elute; free metal and cDTPA-metal complex. 
However, when SCN-Bz-EDTA was chelated with indium several chromatographic 
peaks were resolved. The only peak that could be identified with confidence was 
the unreacted SCN-Bz-EDTA-ln, eluting at 22 min (peak A). This was suggested 
because of the reduction in peak area that occurred when the SCN-Bz-EDTA 
sample contained bradykinin. Molecular mass spectrometry would be required to 
identify the In-complexes formed during chelation. Figure 4-1 l b and Figure 4-1 Id 
show the LC-ICP-MS chromatograms of bradykinin derivatised with SCN-Bz-
EDTA and chelated with indium in ammonium citrate and sodium acetate 
respectively. The LC-UV/vis traces prior to indium chelation suggested that 
derivatisation of bradykinin was successful. However, the similarity of the two 
corresponding LC-ICP-MS traces suggested that no derivatised bradykinin had 
been chelated with indium. A possible explanation for this is that, once derivatised, 
the peptide(s) blocked the chelation sites. 
134 
14D000 
S 100000 
40000 
140000 
120000 
S 100000 
3 GOOOO 
ZOOOO 
140000 
120000 
S 100000 
g 80000 
u 
40000 
20000 
0 
5 10 15 
Time ruin 
S 10 IS 
a S C N - B z - E D T A 
Ammoinum citrate 
b SCN-Bz-EDTA-bradykinin 
Ammoinum citrate 
TliTwJMln 
C SCN-Bz -EDTA 
Sodium Acetate 
100000 
S 80000 
2 60000 
20000 
d SCN-Bz-EDTA-bradykinin 
Sodium Acetate 
Figure 4-11 L C - I C P - M S chromatograms. with detection at m/z 115 of S C N - B z - E D T A chelated 
to indium and S C N - B z - E D T A derivatised bradykinin chelated to indium in ph 6 ammonium 
citrate or ph 6 sodium acetate buffer respectively. Peak labelled A, S C N - B z - E D T A - l n . 
Chromatograms: a, SCN-Bz -EDTA- ln in ammonium citrate pH 6; b, S C N - B z - E D T A -
bradykinin-ln in ammonium citrate pH 6; c , SCN-Bz -EDTA- ln in sodium acetate pH 6; d, S C N -
Bz-EDTA-bradykinin- ln in sodium acetate ph 6. 
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4.3.3 So/ /d Phase Extraction 
The LC/UV-Vis chromatogram in Figure 4-12 sliows a separation of the peptide 
mixture used as a reference for solid phase extraction. Peptides loaded onto the 
SPE tip were recovered Into six fractions: unretained fraction (sample loading); 
0.1% TFA wash fraction; and the four ACN fractions (representing a step gradient 
elution). Table 4-3 shows the recoveries of the peptides from the CI8 SPE 
column, the recoveries were calculated as a percentage by comparing the peak 
area of the fractionated peptides to the total peak area obtained from a reference 
sample. The peptides were identified as the following: peptide 1. Gly-Tyr (Mw 
238.2, hydrophilicity -1.1); peptide 2. Val-Tyr-Val (Mw 379.5. hydrophilicity -1.8); 
peptide 3, Leu-enkephalin (Mw 555.6, hydrophilicity -1.3); peptide 4, Met-
enkephalin (Mw 573.7, hydrophilicity -1.2); and peptide 5. angiotensin II (Mw 
1046.2, hydrophilicity -0.3); based on molecular weights and hyrdophilicity of each 
peptide respectively using a peptide property calculator^^V 
The SPE of the peptide mixture confirmed that peptides can be retained on the 
SPE column and extracted into fractions. The first fraction was the peptide loading 
itself, however, it was calculated that up to 55% of the first peptide was not 
retained. The second fraction was a peptide wash, used to remove any unwanted 
sample matrix, two of the peptides were eluted during this step suggesting that 
relatively small and polar peptides were not retained on the SPE column. The next 
fraction was a 25% ACN which removed the remaining peptides in the fraction. 
The next three fractions increased the ACN elution strength; however, these 
fractions did not contain any retained peptides. The SPE investigation suggested 
that SPAD can be utilised to derivatise peptides on solid phase sorbents. 
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Figure 4-12 H P L C chromatogram with UV/vis detection at 220nm of a reference peptide 
mixture sample . 
Table 4-3 Fractionation and recovery of L C peptide mix us ing C18 S P E column. 
Peptide Retention Time (Min) 
Recovery in the fraction ° (%) 
1 2 3 
1 4.55 55 28 15 
2 6.0 0 17 79 
3 6.55 0 0 99 
4 7.40 0 3 97 
5 7.8 0 0 100 
° Fractionation of peptides carried out a s descr ibed in experimental sect ion (5.2.3). After 
loading three fractions were collected (1) unretained, (2) peptide w a s h (0.1% TFA) and (3) 
peptide elute (0.1% T F A in 25% ACN) . 
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In addition to SPAD. SPE can be used to isolate analytes of interest from other 
interfering analytes as shown in Figure 4-13, the solid phase extraction of 
bradykinin derivatised with SCN-Bz-EDTA. The sample was extracted into several 
fractions, Figures 4-13b to Figure 4-13j. Figure 4-13a shows the original sample 
prior to SPE with peaks labelled: A. bradykinin; B, SCN-Bz-EDTA derivatised 
bradykinin; C, SCN-Bz-EDTA; and D. SCN-Bz-EDTA by-products. Figure 4-13b 
shows the sample loading step, in that fraction some of the unreacted SCN-Bz-
EDTA was eluted from the SPE tip, however no other sample analytes were 
eluted, this would suggest that either the SPE tip was overioaded with SCN-Bz-
EDTA or the SCN-Bz-EDTA formed into by-product complex and was eluted in this 
fraction. Subsequent fractions increased in eluent (ACN) strength starting from 
0.1% TFA to 0.1% TFA in ACN. No analytes of interest where eluted in the three 
fractions. Bradykinin was eluted in the 15% and 25% ACN fractions (Figures 4-13f 
and 4-13g), though majority of the bradykinin was eluted in the latter. In addition, 
the 25% ACN fraction eluted the majority of the derivatised bradykinin as well as a 
SCN-Bz-EDTA by-product. The remaining unreacted SCN-Bz-EDTA was eluted in 
the remaining ACN fractions. No LC-ICP-MS data was obtained from the SPE of 
derivatised bradykinin because of the inefficient chelation method. However, it has 
been shown that derivatised peptide can be isolated from excess reagents; 
therefore the SPE method can be applied to isolate chelated peptides. 
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Figure 4-13 H P L C chromatograms with UV/vis detection at 220nm of the solid phase 
extracted fractions from the derivatisation reaction of bradykinin with S C N - B z - E D T A . Peaks 
identified from retention times a s : A, bradykinin; B, bradykin in-SCN-Bz-EDTA; C , S C N - B z -
E D T A ; and D S C N - B z - E D T A by-products 
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4.3.4 Solid Phase Analytical Derivatisation 
Initial experimental data showed that the derivatisation of peptides on the solid 
phase using cDTPA was not successful, as all peptides and reagent were eluted 
from the solid phase sorbent by the DMSO loading solvent in the derivatisation 
fraction. The peptide eluted from the solid phase sorbent due to the polarity of 
DMSO. Unfortunately, cDTPA was not soluble in any of these solvents, and 
hydrolysed when dissolved in water, so DMSO was the only effective solvent for 
derivatisation. Table 4-4 shows some of the other solvents and their respective 
polarities compared to water that were used for solid phase derivatisation. 
Table 4-4 Relative polarity and the solubility of c D T P A in the organic solvents. 
Organic Solvent Relative Polarity ^ c D T P A solubility 
DMSO 0.444 Y e s 
Acetonitrile 0.460 No 
Tetrahydrofuran 0.207 No 
Ether 0.117 No 
Acetone 0.335 No 
Water 1.000 Y e s 
° Relative polarity compared to water 
Hence. SCN-Bz-EDTA (Figure 4-2) was selected as the reagent of choice for 
SPAD, because the reagent is soluble in water, a major factor for SPAD. The 
derivatisation conditions used for SPAD were similar to the optimised conditions 
used for the solution phase derivatisation of bradykinin. The trivalent metal 
addition step was excluded, due to lack of chelation with derivatised peptides. The 
reaction temperature was 37°C, maintained using a water bath, with a reaction pH 
of 8. The flow rate through the solid phase column was maintained at 0.1 ml min'\ 
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The eluent from each step in the SPAD method was collected and analysed by 
separately by HPCL-UV/vis. All peaks were identified by retention times. 
Figure 4-14a shows the peptide load and, as expected, no peptide was eluted 
from the column. The next step was the on-column derlvatisation. this resulted in 
Figure 4-14b, which shows elution contained a small amount of SCN-Bz-EDTA. 
Next, an incremental elution of the retained compounds was performed, starting 
with 25% ACN (Figure 4-14c) which eluted underivatised bradykinin. Next, 50% 
ACN (Figure 4-14d) eluted bradykinin and SCN-Bz-EDTA derivatised bradykinin. 
All the remaining bradykinin was eluted in the 75% ACN fraction, along with more 
derivatised bradykinin and unreacted SCN-EDTA (Figure 4-13e). The final fraction 
was the 100% ACN fraction which eluted the remaining derivatised bradykinin and 
unreacted SCN-Bz-EDTA (Figure 4-13f). The derivatisation efficiency was 
calculated based on peak area of the underivatised bradykinin, and was 
determined to be 5%. This suggested that derivatisation of peptides using SCN-
Bz-EDTA on a solid phase sorbent was not feasible. The low derivatisation 
efficiency was probably due to the actual derivatisation being slow and solid phase 
derivatisation reactions are required to be rapid due to the short interaction time 
for the derivatisation reaction to occur. The preconcentration effect was not 
observed during these experiments as the elution volume was greater than the 
sample loading volume. However, the majority of the SCN-Bz-EDTA derivatised 
bradykinin was separated from the derivatisation reagent which suggests that 
solution phase derivatisation can be utilised prior to SPE. 
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Figure 4-14 H P L C chromatograms, with UV/vis detection at 220nm of the fractions collected 
fromsolid phase analytical derivatisation of bradykinin with isothiocyanato-benzyl-EDTA. 
Peaks were identified: A. bradykinin; B, S C N - B z - E D T A derivatised bradykinin; C , S C N - B z -
EDTA. 
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4.4 Conclusions 
Different techniques have been investigated for the derivatisation of complex 
samples such as the evaluation of a monoreactive bifunctional chelating agent and 
solid phase analytical derivatisation and solid phase extraction. These 
investigations have stemmed from the inherent disadvantage of using cDTPA as a 
derivatisation agent. cDTPA derivatisation of a peptide mixture resulted in the 
formation of additional by-products from intermolecular and intramolecular species 
due to the reagent containing two reactive groups. 
The use of a monoreactive isothiocyanate-benzyl-EDTA for the derivatisation of a 
peptide mixture resulted in no additional by-products being formed. However, it 
was noted that the instability of the reagent over a period of time complicated 
analysis. In addition, the reagent was found not to chelate to either indium or 
europium once derivatised which rendered ICP-MS detection and quantitation 
ineffective. To improve the derivatisation efficiency between peptide(s) and SCN-
Bz-EDTA, the use of solid phase analytical derivatisation was investigated; 
subsequent analysis suggested that efficiency could not be improved compared to 
the original solution phase derivatisation. However, a benefit was that the selective 
elution of the derivatised products and isolation from reagents suggests that SPE 
can be utilised prior to LC-UV/vis analysis. Further investigations in to improving 
the current labelling strategy is ongoing, reagents such as SCN-Bz-DTPA. The 
reagent was selected due to the success of chelation of indium and europium to 
the DTPA chelating agent. As well as, utilising solid phase extraction to isolate 
derivatised and chelated peptides. 
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CHAPTER 5 RELATIVE QUANTITATION OF COMPLEX SAMPLES 
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Chapter 5 
5. INTRODUCTION 
The analysis of complex samples requires the use of various sample handling 
techniques, such as the solid phase extraction and pre-fractionation to remove 
matrix interferences and reduce sample complexity respectively. We have 
previously shown that monoreactive BFCAs such as. isothiocyanate-benzyl-EDTA 
can be used to derivatise relatively complex samples, without the formation of 
unwanted peptide by-products. In addition solid phase extraction allowed the 
isolation of the analyte from excess reagent prior to analysis. 
In this chapter, the relatively quantitation of peptide samples is described by 
combining the methods and techniques discussed in the previous chapters using 
isothiocyanate-Bz-DTPA as the BFCA. 
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5.1 Relative Quantitation of Complex Samples 
Current relative quantitation methods employ a variety of techniques to either 
remove excess reagent, underivatised peptides or enrich specific peptides. For 
example, the first generation ICAT^® reagent contains a biotin group attached to 
afford the isolation of tagged peptides by biotin/avidin chromatography or by using 
a selective capture/enrichment step to isolate peptides containing cysteine and 
histamine'*®. 
In the previous study it is shown that derivatised peptides can be isolated from the 
derivatisation reagents using solid phase extraction (section 4.3.3). This isolation 
and selective extraction allows derivatisation and chelation reagents to be used 
excess reagents. Hence, increasing derivatisation efficiency and allowing 
fractionation of complex samples. 
5,1.1 Isothiocvanate-benzvl-DTPA 
Based on previous research isothiocyanate-benzyl-DTPA (SCN-Bz-DTPA) was 
selected as an alternative BFCA to SCN-Bz-EDTA. because of the relative 
optimised conditions for isothiocyanate reactions with peptides and successful 
chelation of trivalent metals to DTPA. 
146 
5.2 Experimental 
The methods described in this section utilise the procedures described in the 
previous chapters such as peptide derivatisation with isothiocyanate, differential 
Isotopic labelling using europium for relative quantitation and solid phase 
extraction. 
5.2. t Reagents and Standards 
Bradykinin acetate. HPLC peptide mix, sodium acetate, sodium carbonate, 
ammonium carbonate and trifluoroacetic acid (reagent grade) were purchased 
from Sigma Aldrich, (Poole. Dorset, UK). HPLC grade acetonitrile and methanol 
were obtained from Fisher Scientific UK Ltd. (Loughborough, Leicestershire UK). 
Ammonium bicarbonate was purchased from Fluka. Sigma Aldrich, (Poole, Dorset, 
UK). Isothiocyanate-benzyl-DTPA was purchased from Macrocyclics (Dallas, 
Texas, USA). Distilled deionised water (DDW) 18.2 MQ, was obtained using an 
Elga Maxima water purifying system. ^^^Eu-enriched europium (Eu203 99.24% 
enriched) was purchased from CK Gas Products, (Hampshire, UK). A standard 
ICP-MS solution of natural europium was purchased from Alfa Aesar (Heysham, 
UK). Indium atomic spectroscopy standard was purchased from VWR International 
(Poole, Dorset, UK). 
5.2.2 Instrumentation 
All LC analyses were performed using the Luna CI 8 (2) column (Phenomenex, 
Macclesfield, UK) for reversed phase LC-UV/vis and LC-ICP-MS analysis. The 
mobile phase was a binary system of: eluent A. water containing 0.05% formic 
acid (v/v); and eluent B. acetonitrile containing 0.05% (v/v) formic acid. The linear 
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gradient employed started at 100% A, changing to 100% B over 20 minutes. The 
flow rate was 1 ml min'^ with an injection volume of 25 |iL for all analyses. 
The LC system used for the UV/vis and UV/vis-ICP-MS analysis was a HP 1090 
liquid chromatograph (Agilent Technologies. Stockport, UK). Element specific 
detection was performed using quadrupole ICP-MS (VG PlasmaQuad 3, Thermo 
Elemental. Winsford. UK). The ICP-MS sample introduction system consisted of a 
1.0 ml min'^ microMist nebuliser and a cyclonic spray chamber both purchased 
from Glass Expansion (AUS). The LC outlet was connected to the ICP-MS 
nebuliser via 2 m of Teflon tubing (1/16" x ID 0.18mm). A membrane desolvator 
(Vestec Corporation. Texas. USA) was connected between the spray chamber 
(Nebuliser) and torch to remove organic solvents. The dry aerosol exiting the 
desolvator was then transferred to the ICP torch via 1 m of 0.25 in. i.d. Tygon 
tubing. Operating and data acquisition conditions are shown in Table 5-1. 
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Table 5-1 Operating and data acquisit ion condit ions for Quadrupole ICP-MS. 
ICP 
Nebuliser gas flow / L min"^ 1.2 
Auxiliary gas flow / L min"^ 0.8 
Coolant gas flow / L min'^ 14.0 
RF forward power / W 1350 
Nebuliser 1.0 ml min"^ Micromist 
Spray chamber 
Torch 
Jacketed quartz cyclonic (room temperature) 
Quartz fassel-type 
Interface 
Sampling cone Nickel, 1mm i.d. 
Skimmer cone Nickel, 0.7mm i.d. 
Time Resolved Analysis 
Masses monitored ^^^Inor^^^Eu, ^"Sm, ^ " E u . ^^Sm 
Data Acquisition Peak Jump 
Dwell time / ms 10 
Channels per mass 5 
Membrane Desolvation 
Sweep gas Argon 
Desolvation gas flow / L min'^ 0.9 
Desolvation temperature / °C 80.0 
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5.2.3 Peptide Derivatisation and chelation 
Bradykinin (0.2 g 0.2 mM) was derivatised according to the optimised method in 
section 4.2.3 with 0.2 g of SCN-Bz-DTPA (0.4mM) with a futher 0.1 g of 0.1 M 
sodium carbonate buffer (pH 8) was added to give a final mass 0.5 g. The sample 
were left to react over 2 hrs in a 37°C water bath. The chelation of trivalent metal 
to the SCN-Bz-DTPA derivatised peptides was performed according to the method 
in section 2.2.4. After two hours of derivatisaiton, a 0.1 g aliqout of the derivatised 
bradykinin sample was added separately to 0.1 g indium (0.32 mM). The resulting 
was then further diluted to 10 g using 0.1 M sodium acetate buffer adjusted to pH 
6 using acetic acid and left to stand for 30 minutes. The remaining derivatised 
bradykinin sample was analysed by LC-UV/vis to determine whether derivatisation 
was successful. 
5.2.3.1 Peptide Mix Derivatisaiton and Chelation 
A HPLC peptide mixture (0.2 g) with a total peptide concentration of 0.2 mM was 
derivatised with SCN-Bz-DTPA (0.2 g 0.4 mM) with a futher 0.1 g of 0.1 M sodium 
carbonate buffer (pH 8) was added to give a final mass 0.5 g in a similar manner 
to the method described in section 5.2.3. The sample was derivatised for 24 hours 
at 37°C in a water bath. The chelation of indium to the derivatised peptides was 
performed by adding 0.1 g of indium (0.32 mM) to 0.1 g of derivatised peptides 
with further dilution using 10 g of 0.1 M sodium acetate buffer pH 6 and left to 
stand for 30 minutes. 
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5.2.4 So//d Phase Extraction and Relative Quantitation 
Relative quantitation was performed according to the method described in section 
3.3.3. Bradykinin (0.2 g 0.5 mM) was derivatised with SCN-Bz-DTPA (0.2 g 2 mM) 
the sample was futher diluted to 0.5 g with 0.1 M sodium bicarbonate pH 8. A 0.1 
g aliquot of the derivatised sample was chelated with natural europium (0.1 g 1 
mM). Using the chelation method described in section 2.2.4. the sample was then 
further diluted using 9.dg of sodium acetate to adjust the pH to 6. Additionally 
samples were prepared containing 0.5 mM, 0.25 mM and 0.125 mM of bradykinin 
using the same method derivatlsation and chelation as above, however chelated 
with enriched europium (ImM). The chelated samples were left to stand for 30 
minutes to ensure chelation. 
Once chelated equal gravimetric amounts of the enriched ^^^Eu labelled peptides 
(0.5 g) were combined with natural Eu labelled peptides (0.5 g) and left to stand 
for 10 minutes for equilibration prior to SPE or LC-ICP-MS analysis. Solid phase 
extraction followed the method described in section 4.2.6, where labelled samples 
were extracted into several fractions, using incremental eluent strenght. The solid 
phase extracted sample was analysed by LC-ICP-MS to validate the Eu isotope 
ratio obtained from the SPE method. 
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5.3 Results and Discussion 
5.3.1 Peptide Derivatisation and Chelation 
The LC-UV/vis chromatogram in Figure 5-1 and 5-2 shows the derivatisation of 
bradykinin and a HPLC peptide mixture using SCN-benzyl-DTPA respectively. The 
method for derivatisation was previously described in section 4.3.4 for the reaction 
between isothiocyanate and peptides. The derivatisation efficiency of the reaction 
between bradykinin and isothiocyanate-benzyl-DTPA was determined to be 55% 
based on peak areas of underivatised bradykinin in Figure 5-1B. In addition, the 
derivatised bradykinin chromatogram (Figure 5-1B) suggested that more than the 
expected number of peaks were eluted. The masses of the derivatised products 
could not be determined by infusion molecular mass spectrometry due to the high 
sodium content in the derivatised products. 
Figure 5-2 shows the derivatisation of a HPLC peptide mixture, from the peak 
areas of the underivatised peptides, the derivatisation efficiency of reaction 
between SCN-Bz-DTPA and peptide mixture was determined to be 46% based on 
the disappearance of the peptides. However, it was observed that though the 
underivatised peptides reduced in peak area by 46% between the reference and 
derivatised samples there was no increase in SCN-Bz-DTPA derivatised peptide 
peaks. This could either suggest that the derivatisation efficiency was affected at 
low analyte concentration or that the derivatised peptide complexes are not stable 
in solution and broken down during the derivatisation reaction. 
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Figure 5-1 H P L C chromatograms with UV/vis detection at 220nm of bradykinin derivatised 
with SCN-Bz l -DTPA: a, bradykinin; b, S C N - B z - D T P A derivatised bradykinin; Peaks identiHed 
a s : A, bradykinin; B. SCN-Bz-DTPA-bradykinin and C , S C N - B z - D T P A by-products. 
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Figure 5-2 H P L C chromatograms with UV/vis detection at 220nm of a H P L C peptide mixture 
derivatised with SCN-Bz l -DTPA: a, bradykinin; b, S C N - B z - D T P A derivatised bradykinin; 
P e a k s identified a s : A - E , underivatised peptides; (1-5), S C N - B z - D T P A derivatised peptides, 
and F, S C N - B z - D T P A by-products. 
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The corresponding LC-ICP-MS chromatograms for the derivatised bradykinin and 
peptide mixture are shown in Figure 5-3 and 5-4 respectively. The derivatised 
peptides were chelated with indium in sodium acetate buffer at pH 6.1 and 6.5. 
The effect of pH of the sodium acetate buffer was critical to chelation, it was seen 
that more indium was chelated to DTPA at a sodium acetate buffer of pH 6.1 than 
at buffer pH of 6.5. The chromatogram in Figure 5-3 contains three resolved peaks 
that correspond to: A, free In^*; B. SCN-benzyl-DTPA-ln; and C, bradykinin-SCN-
Bz-DTPA-ln based on the respective retention times. Figure 5-4 shows the 
chromatogram of derivatised and indium chelated peptide mix. Peaks that are can 
be determined are: A, free In^* and B, SCN-benzyl-DTPA-ln. In addition, two 
smaller peaks were visible at 9.8 min (C) and 10.2 min (D). These could be 
derivatised peptides, however mass spectrometry confirmation would be required. 
A possible explanation to the reduced derivatisation efficiency for the HPLC 
peptide mixture is that the relative concentration of the individual peptides was 
approximately 5 times less than the bradykinin. This would suggest that the 
reagent is not suitable for derivatisation at low concentrations; this has been 
previously seen with cDTPA that below certain concentration efficiency is greatly 
reduced. According to literature on SCN-benzyl-DTPA, the typical molar ratio of 
reagent to analyte is 100:1 in excess of SCN-benzyl-DTPA. However, using this 
amount of excess reagent for derivatisation would not be feasible for the current 
method of analysis by LC-ICP-MS as it would result in inefficient chromatography, 
column and ICP-MS detector deterioration. A possible solution would be to remove 
excess reagents, prior to analysis such as using solid phase extraction. 
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Figure 5-3, ICP-MS chromatogram at m/z 115 of isothiocyanate-benzyl-DTPA derivatised 
peptide mix with indium chelation. Peaks labelled; A, free In' 
indium labelled bradykinin. 
B, SCN-Bz -DTPA- ln ; C , 
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Figure 5-4, ICP-MS chromatogram at m/z 115 of isothiocyanate-benzyl-DTPA derivatised 
peptide mix with indium chelation. Peaks labelled; A, free In^ ; B, isothiocyanate-benzyl-
DTPA-ln; C and D, possib le indium labelled peptides. 
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5.3.2 So//'d Phase Extraction of Europium Labelled Peptides 
Previous investigation for the use of the solid phase analytical derivatisation of 
peptides approach showed that is was not suitable for the derivatisation of 
peptides using isothiocyanate based BFCA's. This was primarily due to the time 
required for the reagent to be on the solid phase for derivatisation. However, solid 
phase extraction can be applied to method after derivatisation and chelation. The 
advantage of using solid phase extraction prior to LC-ICP-MS analysis is that 
derivatisation and chelation reagents can be used in a much greater excess 
hence, ensuring near complete derivatisation and chelation. In addition, excess 
reagents can be isolated and do not interfere in the subsequent analysis. 
Figure 5-5 shows the LC-ICP-MS chromatograms of europium labelled bradykinin 
solid phase extracted. The sample was analysed by prior to SPE by LC-ICP-MS 
and the resulting chromatogram is shown in Figure 5-5a. The chromatogram 
contains for four resolved components: peaks A, Free Eu^*; B, SCN-Bz-DTPA-Eu; 
C. bradykinin-SCN-Bz-DTPA-Eu; and D. SCN-Bz-DTPA-Eu by-product. The 
resulting SPE is shown in LC-ICP-MS chromatograms Figure 5-5b through to 
Figure 5-5j. It was shown that majority of the free Eu^ "*" was eluted in the 5% ACN 
fraction (Figure 5-5d). 
In Figure 5-5f. the 15% ACN fraction all of the SCN-Bz-DTPA-Eu was eluted off 
the SPE tip, however, this fraction also contained the SCN-Bz-DTPA-Eu by-
product and a fraction of the Eu labelled bradykinin. In contrast, Figure 5-5g 25% 
ACN fraction contained only the Eu-labelled-bradykinin. Subsequent fractions 
Figures 5-5h through to Figure 5-5j resulted in no discernible amount of respective 
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peaks being eluted. It was noted that SPE improved the chromatographic peak 
shape of the resulting eluted peaks. 
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Figure 5-5 L C - I C P - M S chromatograms at m/z 151 detection of the solid phase extracted 
fractions from the derivatisation and chelation of bradykinin with S C N - B z - D T P A and natural 
europium respectively. Peaks identified from retention times a s : A, free Eu^*; B, S C N - B z -
D T P A - E u ; C , bradykin in-SCN-Bz-DTPA-Eu; and D , S C N - B z - E D T A - E u by-products. 
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5.3.3 So//d Phase Extraction and Peptide Relative Quantitation 
Relative quantitation of peptides was achieved with europium labelling and the 
selective isolation and extraction. Using the method described in section 5.2.3 
samples were solid phase extracted and the only the 25% ACN fraction analysed 
by LC-ICP-MS. In addition, to validate the measured isotope ratio obtained 
through SPE the original sample prior to SPE was analysed by LC-ICP-MS shown 
in Figure 5-6. 
Using the pseudo steady approach described in section 3.2.3 and subsequent 
isotope dilution mass spectrometry (IDMS) analysis the resulting peptide amounts 
in the sample were determined. Table 5-2 compares the theoretical peptide ratio 
expected to the measured IDMS peptide ratio with the respective relative errors 
and expanded uncertainty on the measured peptide ratio shown for either 
extracted or unextracted europium labelled bradykinin. 
Samples 1-6 show the relative quantitation of bradykinin it was observed that there 
was a significant difference in the theoretical and measured peptide ratios 
approximately 50% or greater in some cases whether samples were solid phase 
extracted or not. In addition, a natural europium labelled sample was analysed and 
in those cases ratios measured and theoretical ratios did not agree. However it 
was noted that the there was good agreement in the measured ratios between 
extracted and unextracted samples. This suggested that SPE can be utilised for 
sample isolation and extraction. 
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Figure 5-6 Multi-isotope ICP-MS chromatogram of a derivatised peptide mixture containing 
bradykinin and substance P chelated with Eu using gradient elution profile 1, ^^^Eu black 
and ' " E u red. Resolved peaks; A, free E u ^ ; B, SCN-Bz-DTPA-Eu^* : and C. Bradykinin-SCN-
Bz-DTPA-Eu^* . 
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Table 5-2 Relative quantitation of peptides comparing theoretical and measured peptide 
ratios. 
Sample Peptide Concentration 
im 
Theoretical 
Peptide 
ratio 
nx/ny 
Peptide 
ratio* 
nx/ny 
Measured 
± Relative ± Relative 
error (%) Expanded 
Uncertainty (%) 
Natural Bradykinin S P E 0.8 1.092 0.9382 23.284 8.695 
Natural Bradykinin* 0.8 1.092 0.9325 22.652 8.686 
1 Bradykinin S P E 0.8 3.901 1.378 64.6 8.677 
2 Bradykinin* 0.8 3.901 2.023 48.1 6.537 
3 Bradykinin S P E 0.8 2.005 1.059 47.0 4.389 
4 Bradykinin* 0.8 2.005 0.987 50.6 5.836 
5 Bradykinin S P E 0.8 1.195 0.634 46.7 5.565 
6 Bradykinin* 0.8 1.195 0.608 48.9 5.814 
* represent the LC- ICP-MS analysis performed without S P E 
Subsequent investigation into the cause of these m/z 151 biased peptide ratios 
suggested that the problem was either with the quadrupole analyser or the 
software (PlasmaLab, Thermo Elemental, Winsford, UK) was not integrating the 
151 ion signal. The instrument was integrating one of the channels for m/z 151 
twice as high as other the other channels, which results incorrect measured 
^"EU/^^^EU ratio and hence incorrect peptide ratio. This scenario is exaggerated 
when enriched ^^^Eu is spiked into the sample as seen in Table 5-2 suggesting a 
bias towards m/z 151. 
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5.4 Conclusions 
Relative quantitation of bradykinin has been achieved with the SCN-Bz-DTPA and 
isotopic labelling with europium with subsequent LC-ICP-MS detection. Solid 
phase extraction was applied to the derivatised and chelated samples to isolate 
and selectively extract the labelled, so that excess reagents do not interfere in the 
analysis. The resulting IDMS analysis, suggested that there was no significant 
difference in the peptide ratios obtained through extraction or not. However, the 
measured peptide ratio and theoretical peptide ratio were significantly with relative 
errors greater than 50% observed. However, investigations suggested that this 
was either due to instrumentation or software faults and not the labelling 
procedure. 
This shows the potential that complex samples can be relatively quantified using 
differential Isotopic labelling with selective Isolation and extraction. However, 
suitable derivatisation reagent must be used and is considered in the next 
potential area of investigation. The SCN-Bz-DTPA reagent has shown the 
potential for monoreactlve derivatisation, however, due to the reagents poor 
stability In solution and loss in reactivity at low analyte concentrations it cannot be 
considered as a viable reagent for relative quantitation. 
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Chapter 6 
6. CONCLUSIONS AND FUTURE WORK 
6.1 Conclusions 
The aim of this work was to develop a method to relatively quantitate peptides 
using ICP-MS detection. Majority of naturally occurring peptides are not detectable 
by ICP-MS and require some form of chemical derivatisation to facilitate ICP-MS 
detection. ICP-MS peptide detection was made amenable through the 
derivatisation of the N-terminal amine group with various bifunctional chelating 
agent (BFCA), cyclic diethylenetriaminepentaacetic acid anhydride (cDTPA), 
isothiocyanate-benzyl-ethylenediaminetetraacetic acid (SCN-Bz-EDTA) and 
isothiocyanate-benzyl-diethylenetriaminepentaacetic acid (SCN-Bz-DTPA). Once 
derivatised with peptides these BFCA were then subsequently chelated with 
trivalent metals such as indium and europium respectively. The detection of these 
element labelled peptides has been achieved using LC coupled with ICP-MS via 
membrane desolvation which facilitated the use of gradient chromatography. 
Using this derivatisation and labelling technique, biologically important peptides 
bradykinin and substance P were relatively quantified. This was achieved by 
derivatising two gravimetrically known amounts of peptide samples with cDTPA 
and subsequently chelating the samples with either natural Eu or enriched ^^^Eu 
respectively. Once chelated, equal amounts of the samples are combined and 
analysed by LC-ICP-MS. The resulting 153/151 Eu isotope ratio is measured using 
the pseudo steady state approach. The blank and mass bias corrected 153/151 Eu 
ratio was used to calculate the relative peptide amount in the original peptide 
samples using a modified isotope dilution mass spectrometry (IDMS) equation. 
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The ICP-MS measured peptide ratio was calculated to be within 2.8% of the 
theoretical peptide ratio. However, it was noted that precision was relatively high 
and hence uncertainty was approximately 13%, which could be attributed to 
plasma instability. 
The peptide-cDTPA and peptide-cDTPA-Eu complexes was characterised using 
ESI-MS and LC-ESI-MS-MS. However, to facilitate ESI-MS detection, 
derivatisation and chelation buffers were changed to ammonium bicarbonate and 
ammonium acetate respectively. The change in derivatisation buffer resulted in an 
additional conformer of the peptide complex being formed. This conformer had a 
different chromatographic retention, however, had the same m/z ratio and collision 
induced fragmentation to the original peptide complex. The original derivatisation 
method in sodium bicarbonate and sodium acetate did not result in the formation 
of the additional conformer. This was evident by the respective LC-ICP-MS 
chromatograms of the peptides in sodium and ammonium based buffers. 
When the cDTPA labelling technique was applied to a relatively complex peptide 
sample, the resulting derivatisation reaction resulted in more than the expected 
number derivatised products being formed. This was due the cDTPA reagent 
containing two reactive groups, v^ich can lead to the formation of intermolecular 
and intramolecular species with one or more peptides. However, once the 
derivatised peptide mixture was chelated, only five europium chelated peaks were 
chromatographically resolved. This suggests only the singly derivatised form of the 
peptides are detectable by LC-ICP-MS. However, the relative quantitation would 
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be inaccurate because it cannot be predicted how much of each individual peptide 
is complexed in the intermolecular and intramolecular species. 
A monoreactive BFCA. isothiocyanate-benzyl-EDTA (SCN-Bz-EDTA) was used to 
overcome the formation of the additional by-products. The reagent was successful 
derivatising a complex mixture of peptides, which resulted in the no additional by 
products being formed, subsequently the derivatised peptide(5) was labelled with 
indium. However, chelation of the derivatised peptide(s) was not successful using 
indium and europium using different buffers and varying pH. It was also noted that 
the derivatisation efficiency was significantly lower when compared to the 
derivatisation with cDTPA by approximately 45%. 
To improve derivatisation efficiency solid phase analytical derivatisation (SPAD), 
was employed for peptide derivatisation. The SPAD technique Isolates peptides of 
a solid phase sorbent for derivatisation. The technique allows the use of excess 
and selective isolation of reagents that can potentially interfere with the analytes of 
interest. The derivatised peptides was isolated on a conditioned solid phase tip 
and eluted in fractions of acetonitrile increasing in elution strength. However, a 
decrease in derivatisation efficiency was noticed when comparing solid phase 
derivatisation to solution phase derivatisation. The reduction in derivatisation 
efficiency was due to the reaction time required for derivatisation, solution phase 
required between 2 to 24 hours for derivatisation. and the SPAD method the 
reagent was on column for no longer than two minutes. Although SPAD, did not 
result in the expected increase in derivatisation efficiency, the selective extraction 
of derivatised was implemented into solution phase derivatisation method of SCN-
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Bz-DTPA. Solution phase extraction (SPE) allowed the isolation of derivatised and 
chelated peptides from excess reagents. 
To afford chelation of the isothiocyanate derivatised peptides, SCN-Bz-DTPA was 
selected as an alternative BFCA. The reagent was chelated with indium and 
europium using the same method as cDTPA chelation. The labelled peptides 
(natural and enriched) were combined and solid phase extracted . the labelled 
peptide was isolated from the excess reagents used in derivatisation and 
chelation. The solid phase technique was used to relative quantitate bradykinin 
and compared to relative quantitation obtained from LC-ICP-MS of the original 
combined sample, however, measured isotope ratios were all biased in favour of 
m/z 151, hence rendering relative quantitation ineffective due to either 
instrumentation or software faults. 
169 
6.2 Future Work 
During the course of this work a number of areas have been identified for further 
study. The objectives set out at the start of the research project was to develop a 
method for the relative quantitation of peptides using LC-ICP-MS. Currently the 
method has only been investigated using control situations, for this method to be a 
comparable to current relative quantitation techniques development in the tags, 
labels, and sample preparation of the method must be investigated. 
6.2.1 Labelling / Taaaina Reagent 
Peptide relative quantitation by ICP-MS detection has been shown to afford high 
accuracy and precision. However, the labelling method itself requires additional 
research to become comparable to the other current techniques available, in a 
number of areas such as sample complexity, removal of excess reagents, and 
isolation of labelled analytes. To establish ICP-MS as a routine analytical tool in 
proteomics and relative quantitation, a concerted effort must be made in designing 
and evaluating tags and labels for specific proteomic techniques. This would 
involve several scientific disciplines to synthesise, characterise and analyse these 
tags and labels, rather than the current state of affairs where ICP-MS analysts 
have been evaluating methods for proteomic analysis. Currently tags and labels 
being used for proteomic analysis are ones that are available on the market 
though not designed for a particular application. 
A possibility would be an investigation into the synthesis of specific tags which 
already contain a specifically enriched isotope; this would avoid additional steps 
after the derivatisation. In our laboratory, a tag brominated 
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tris(trimethoxyphenyl)phosphonium (Br-TMPP) was synthesised by Cartwright et. 
a/.^ ® to determine the degree of phosphorylation in peptides. The tag contained six 
bromine atoms and one phosphorous atom, which reacted with the carboxylic 
residue on peptides and carboxylic acids. The Br-TMPP tag was synthesised to 
increase the sensitivity of LC-ICP-MS detected carboxylic acids over the first 
generation TMPP tag. This compound could potentially be used as a template to 
design other similar tags to be used in this manner. 
Considerations for tags and labels: 
Reactive group 
The reactive group must be monoreactive and stable in solution. The reactive 
group can either be amino acid specific such as thiol specific reagents (maleimide, 
iodoacetamide etc) or N-terminal amine specific such as anhydrides 
Isotope/Elemental coding 
The tag should contain four or more enriched isotopes of either ^^^Eu or ^^^Eu, this 
is because most mass spectrometers do not have sufficient sensitivity at unit mass 
resolution. Therefore if the tag contained four or more isotopes v\flth a 2Da mass 
difference this would allow sufficient resolution of tagged peptides for identification 
using molecular mass spectrometry and detection using ICP-MS. In addition and 
once derivatised with the peptide, there is a potential to determine the extent of 
phosphorylation on peptides by monitoring the either ^^^Eu or ^ " E U / P ratio using 
LC-ICP-MS. 
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6.2.2 Immunoassays 
We have previously described the used of solid phase analytical derivatisation for 
sample isolation and preconcentration prior to derivatisation. However, proteomic 
samples can contain many thousands of peptides to isolate, derivatise and detect 
this could possibly overload any LC-ICP-MS system. A simple method to reduce 
the numbers of peptides to be analysed and to isolate key peptides if the use of 
immunoassays. 
Immunoassays can be described as the detection and quantitation of antigens with 
specific antibodies such as Enzyme-Linked Immunosorbent Assay (ELISA), which 
are used to detect antigens and antibodies in biological samples. Performing an 
ELISA involves at least one antibody with specificity for a particular antigen. The 
antigen could be an biological complex, peptide, or protein. For example if 
antibodies can be cultivated that have a specificity for a specific group of peptides 
such as kinins, the peptides can be immobilised on a solid support. Firstly, the 
antibodies are immobilized on the solid support, with the sample passed through 
the wells, specific antigens bind to antibodies through non-covalent bonds and 
conformational fit. Typical ELISA protocol requires a detection antibody to be 
added forming a complex with the antigen which can be detected using optical 
detection by complexing the antigen with a labeled antibody. 
6.2.2.1 Relative Quantitation bv Immunoassay 
The labeling of the peptide for relative quantitation can be achieved with three 
different approaches: 
172 
On-column labeling, derivatisation and chelation of peptides by bifunctional 
chelating agents are carried out in situ. This approach is similar to that to solid 
phase analytical derivatisation and the possible advantages of that approach can 
be maintained such as, excess reagent is removed, preconcentration effect can be 
maintained. However, a consideration to be made is the orientation of the peptide 
within the complex and that the site for derivatisation is obstructed or completely 
unavailable by the antibody. Once derivatised and chelated excess reagent is 
removed from the well and labeled peptides eluted from the immunoassay well 
and combined with the derivatised products from a corresponding immunoassay 
well and analysed by LC-ICP-MS. This approach is similar to the method 
developed by Wallac AutoDELFIA^^. 
Solution phase labeling, the isolated peptides are eluted from the immunoassay 
and then derivatised and chelated. The labeled samples can then be isolated from 
the excess reagent using solid phase extraction. An advantage of this approach is 
that, dependant on derivatisation efficiency all peptides will be labeled and that 
derivatisation sites will not be obstructed. 
Antibody Labeling, this approach is similar to that presented by Baranov et.al.^^, 
using the ELISA approach of two antibodies, the second antibody is tagged with 
natural europium and enriched europium and used to label antigens respectively. 
The Eu-labeled antigens are then eluted of the immunoassay and combined prior 
to analysis by LC-ICP-MS. Advantage of this approach is that it negates the 
derivatisation and chelation steps, and excess reagents can be re-used. A 
possible disadvantage is that the size of the Eu-antibody-antigen complex maybe 
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too large for standard LC columns and that another form of chromatography 
maybe required. 
6.2.3 Proteomic Labeling 
Current state of proteomics and ICP-MS either requires the biomolecules to 
contain heteroatom detectable by ICP-MS or tag or label biomolecules for 
elemental analysis. However, highlighted by Quinn et al.^ no specific tags and 
labels have yet been developed for routine analysis. However, these tags and 
labels require derivatisation of some form which increases analytical time, sample 
handling and with the potential of unreacted reagent interfering in the analysis. 
An alternative method such as metabolic labeling can be used to incorporate 
metals and heteroatoms in to biological samples for ICP-MS detection. Cell lines 
can be grown in media containing either a metal^^ or enriched isotopes such as 
carbon^'' and deuterium^^. This method of isotope labeling has been previously to 
proteomic measurement using ICP-MS detection. A procedure described by 
Polatajka et a/.^ ^^ grew selenised yeast in ^^Se04 rich culture and purified a 
specific tryptic peptide has an internal standard for isotope dilution analysis (IDA). 
Harrington et al7^ applied a similar technique for the detection of copper-
containing protein rusticyanin. Hence, two different samples can be grown in the 
natural or enriched form of a metal to allow relative quantitation. This approach as 
many advantages over chemical derivatisation labelling and tagging as there is no 
requirement for a label/tag therefore derivatisation chelation steps are not required 
and therefore sample isolation from excess reagent is not required. As the element 
labels are incorporated at the earliest possible stage they can be combined 
174 
immediately after extraction from the growth media. This is beneficial to IDMS 
analysis as any effect on the peptide ratio from subsequent sample treatment can 
be ignored as it would be equal for sample and spike. 
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Abstract Bradykinin and substance P have been derivatised 
with cyclic dieihylenetriaminepentaacetic anhydride (cDTPA) 
and subsequently labelled with natural and isotopically 
enriched Eu'"^. This enabled the detection and relative 
quantitation of the peptides using element-selective detection 
by high-performance liquid chromatography inductively 
coupled plasma mass spectrometry ( L C - I C P - M S ) . Relative 
quantitation was achieved by differentially labelling two 
peptide sources, after derivaiisation with cDTPA, using 
natural and enriched ' ^ ' E U respectively. The ' ^ ' E U : ' " E U 
isotope ratio was measured and used to calculate the original 
peptide ratio. The measured ratios came within 5.2% of the 
known ratio. Derivatisation and chelation reactions were 
additionally confirmed using L C - E S I - M S . 
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Introduction 
The derivatisation of molecules to make them amenable to 
detection is a long-established technique in analytical 
chemistry [1]. The addition of a chemical or isotopic label 
allows a target molecule to be distinguished from other 
compounds in a system. The expanding fields of proteo-
mics and genomics require simplified methods for the 
characterisation and quantification of biological macro-
molecules, and the development of reagents for the 
derivatisation of specific functional groups has played a 
vital role in the development of new instrumental methods. 
One well-known example of this approach is the isotope-
coded affinity tag (ICAT) method [2] used to determine the 
relative expression of peptides from diseased and healthy 
stales. In this method, the cysteine residues in proteins from 
two lysate samples are tagged using thiol-reactive labels, 
one of which is isotopically enriched with or '^C, then 
mixed together in a tryptic digest and the resultant peptides 
are analysed by ESI-MS. The isotope ratio of the 
molecular ions yields the relative expression of the proteins. 
Some work involving the elemental labelling of organic 
molecules has started to emerge [3-9], but there has not 
been a concerted effort to design and evaluate isotopically 
labelled tags for element-specific detection. Inductively 
coupled plasma mass spectrometry (ICP-MS) is a prime 
candidate for the application of isoiopic labelling, and 
recent research has demonstrated the potential of this 
approach [7, 8]. In our laboratory, we have used the reagent 
tris(trimethoxyphenyl)phosphonium (TMPP) [10] to label 
organic carboxylic acids with phosphorus to make them 
amenable to detection using ICP-MS [8]. Bifunctional 
chelating agents such as diethylenetriaminepentaacetate 
(DTPA) have been used to label conjugate functional 
groups on peptides and proteins [11], and subsequently 
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chelated wiih ' " i n or other radioactive isotopes to produce 
radiopharmaceuticals. Likewise, other DTPA derivatives 
with maleimide, bromoacetamide and pyridyldithio linkers 
have been used as luminescent probes when chelated with 
Eu^^ and Tb "^^  [12]. Cyclic diethylenetriaminepeniaacetate 
(cDTPA) is the anhydride of DTPA which will form an 
amide bond with the -NH2 terminus of a peptide or protein 
[13]. The advantage of this compound is that it fonms an 
amide bond without the need for any other reagents, and so 
it has been utilised for the derivatisation of amines and 
detection by ICP-MS [4]. 
Experimental 
Instrumentation 
A Luna CI8(2) column (Phcnomenex , Macclesfield, 
UK) was used for LC-UV/vis, LC-ICP-MS and L C -
ESI-MS analysis. The LC system used with UV/vis and 
ICP-MS analysis was a HP1090 liquid chromatograph 
(Agilent Technologies, Stockport, UK), and a Waters 
2695 Separation Module and Waters 2487 dual wave-
length absorbance detector was used with LC-ESI-MS-
MS. The LC mobile phase was a binary system 
consisting of: (A) 0.05% formic acid in water and (B) 
0.05% formic acid in acetonitrile. The mobile phases 
were sparged with helium prior to analysis. Al l analyses 
were performed using 25-|iL sample volumes and a 
1.0 mL min"' flow rate. Two gradient elution profiles 
were employed: (1) a linear gradient elution performed by 
increasing mobile phase B from 0% to 33% over 20 min; 
(2) a nonlinear gradient elution profile where mobile phase 
B was increased from 0% to 15% over 5 min and to 
18.75% over the next 15 min. Element-specific detection 
was performed using quadmpole ICP-MS (VG Plasma-
Quad 3, Thenmo Elemental, Winsford, UK). The LC outlet 
was connected to the ICP-MS nebuliser by 2 m of PTFE 
tubing {\/\6''^\D 0.18 mm). A membrane desolvator 
(Vestec Corporation, Houston, TX, USA) was connected 
between the spray chamber (the nebuliser) and the torch to 
remove organic solvent vapour. Electrospray ionisation 
mass spectrometry was performed in positive ion mode 
using LC-ESI-MS-MS (Micromass Quattro Ultima Pt, 
Micromass, Manchester, U K ) . The LC outlet was 
connected to an ESI-MS-MS and a UV detector via a 
30-cm length of peek tubing ( l / 1 6 " x I D 0.25 mm) 
connected in-line with a flow splitter (Upchurch Scientif-
ic, Oak Harbor, WA, USA). The flow of 1 mL min"' from 
the LC column was split in the ratio 1:9, where 0.1 mL 
min"' was sent to the electrospray ionisation source and 
0.9 mL min"' to waste. The molecular masses to be 
monitored were selected by direct infusion of the appropriate 
sample at 0.1 mL min"' prior to analysis. 
Reagents 
Bradykinin acetate, substance P, cyclic diethylenetriamine-
pentaaceiic anhydride (cDTPA), sodium bicarbonate, and 
sodium acetate were purchased from Sigma Aldrich (Poole, 
UK). Dimethyl sulfoxide (DMSO), ammonium acetate, and 
nitric acid (trace analysis grade) were purchased from 
Fisher Scientific (Loughborough, UK). Ammonium bicar-
bonate was purchased from Sigma Aldrich (Poole, UK). 
'^*Eu-enriched europium (EU2O3 99.24%-enriched) was 
purchased from CK Gas Products (Hook, UK). Standard 
ICP-MS solutions of natural europium and samarium were 
purchased from Alfa Aesar (Heysham, UK). 
Procedure 
Isotopic labelling 
The method used for derivatisation of peptides with 
cDTPA, and chelation with In**^  or Eu''^ was modified 
from Hnatowich et al. [13]. A solution (0.2 g) of cDTPA 
(between 5-5000 | iM) in anhydrous DMSO was added to a 
solution (0.2 g) of peptide (between 2.5 and 2500 j iM) 
buffered to pH 8.3 with either 0.05 M sodium bicarbonate 
for ICP-MS analysis, or 0.05 M ammonium bicarbonate 
for ESI-MS analysis. The ratio of cDTPA to peptide was 
2:1 to ensure an excess of cDTPA; however, too much 
cDTPA compromised the chromatographic separation effi-
ciency. The derivatisation reaction was allowed to proceed 
for 30 min at room temperature. The resultant peptide-
cDTPA conjugate solution (0.1 g) was labelled with In^ "*" or 
Eu^^ by adding a solution (0.1 g) of the appropriate metal 
(between 7.5-7500 ^ M ) buflered to pH 6 with either 
0.05 M sodium acetate for ICP-MS analysis, or 0.05 M 
ammonium acetate for ESI-MS analysis. The molar ratio of 
trivalem metal to cDTPA was 2:1 to ensure chelation with 
the cDTPA moiety. Chelation was achieved by agitating the 
solution at room temperature for 30 min. 
isotope ratio analysis and relative quantitation 
A peptide solution, x, amount w ,^ was labelled with natural-
abundance Eu"*^ , and a peptide solution, y, amount M ,^ was 
labelled with isotopically enriched Eu^^. The separate 
solutions were then combined and the ' ^ ' E U : ' " E U isotope 
amount ratio was determined afrer separation and detection 
by LC-ICP-MS. The relative amounts of peptide in the two 
original solutions could then be calculated using the isotope 
^ Springer 
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dilution equation (Eq. I ) , after correction for mass bias 
using the '*^Sm:'^''Sm isotope amount ratio. 
Hi ( I ) 
where is the amount of peptide in solution x labelled 
with natural Eu; tiy is the amount of peptide in solution y 
labelled with enriched Eu; is the atom fraction of natural 
' ^ ' E U ; is the atom fraction of natural '^^Eu; Ay is the 
151 Eu; By is the atom fraction of atom fraction of enriched 
enriched '^• 'EU; and R is the (mass bias) corrected 
i5 i£y . i53£u isotope amount ratio. The ratio njriy gives the 
amount ratio of the peptides in the two original solutions 
and, by extension, can be used to determine the relative 
amounts of peptide in two difTerent cell states. 
Results and discussion 
Preliminary smdies 
Preliminary studies performed using LC-UVA^is detection 
at 254 nm indicated that the derivatisation reaction 
efficiency was >94%; however, the efficiency was much 
poorer at lower concentrations when ICP-MS was used for 
detection. The chromatogram of derivatised bradykinin 
(data not shown) contained two peaks corresponding to 
the derivatised peptide, cluting at 14.6 and 14.8 minutes 
respectively. The presence of two separate peaks may have 
been caused by derivatisation with one or both of the 
cDTPA functional groups, thereby yielding more than one 
product. However, subsequent ESl-MS analysis indicated 
that the molecular ions at these retention times had identical 
m/z, so it is more likely that the two peaks were due to 
different conformers with slightly different eluiion times, 
but this was not confirmed. 
Optimisation for ICP-MS and ESl-MS 
The next step was to chelate the derivatised peptide with an 
appropriate elemental label and perform element-specific 
detection using ICP-MS. Europium was chosen as the 
isotopic label because it is relatively inexpensive, contains 
only two isotopes which can be readily corrected for mass-
bias using a samarium spike, and is free from polyatomic 
interferences under the operating conditions used. It was 
also necessary to undertake complementary analysis using 
ESI-MS to confirm the expected derivatisation products. 
Positive ion mode ESI-MS was employed because it is the 
preferred and most sensitive mode of detection for multiply 
charged pnateins and large biomolecules. 
Derivatisation of bradykinin with cDTPA and chelation 
with Eu^^ was initially performed using sodium bicarbon-
ate and acetate buffers respectively, however, these were 
changed to ammonium buffers for ESI-MS to eliminate the 
possibility that sodium adducts might form during the 
ionisation process. The ESI-MS mass spectra shown in 
Fig. 1, obtained by infusion of the derivatised products, 
confirmed that the reactions had successfully resulted in 
bradykinin-cDTPA and bradykinin-cDTPA-Eu conjugates. 
An isotopic pattern was not observed using positive ion 
mode ESl-MS due to insufficient mass resolution; howev-
er, separate negative ion mode ESI-MS showed the isotopic 
pattern for natural europium of the derivalised peptides. 
The results of further complementary analysis using L C -
ESI-MS-MS and LC-ICP-MS are shown in Fig. 2. Deriva-
tisation using an ammonium acetate buffer (used for ESI-
MS) yielded two peaks at 12.3 and 14.8 min (Fig. 2b-<l) and 
confirmation that both of these peaks were due to bradyki-
nin-cDTPA-Eu was provided by monitoring masses 
corresponding to the MRM (multiple reaction monitoring) 
transitions 1584>904 (Fig. 2c) and 1584>540 (Fig. 2d). 
These transitions were the result of loss of a cDTPA-Eu-
arginine group and a bradykinin molecule from the brady-
kinin-cDTPA-Eu complex, respectively. The peak at 
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Fig. I Infusion E S I - M S mass spectra confirming the formation of: a 
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Fig. 3 Multi-isoiope chromatogram of bradykinin derivatised with 
cDTPA and chelated with isotopically enriched Eu^* obtained using 
ICP-MS detection ai m/= 151 and 153 
12.3 min was identified as bradykinin-cDTPA-Eu using 
ESI-MS-MS, but was not visible in the ICP-MS trace 
(Fig. 2a) when using sodium aceiaie as the buffer, either 
because it was not formed under these conditions or it was too 
close to the tail of the cDTPA-Eu peak to be observed above 
the noise. The presence of two weil-resolved peaks in the 
chromatogram with identical masses is probably the result of 
the formation of two different products during the conjugation 
reaction. 
Relative peptide quantitation 
A pseudo steady-state approach was used to determine the 
isotope amount ratios from the multi-isotope chromato-
grams obtained by LC-ICP-MS [14]. \n order to obtain the 
best accuracy, all data points were corrected by baseline 
subtraction, and the ' ^ ' E U : ' ^ ^ E U isotope amount ratio was 
mass-bias-corrected by interpolation using the '^^Sm:'"Sm 
isotope amount ratio and the Russell expression [14]. The 
Table 1 Relative peptide ratios determined using L C - I C P - M S and 
the mass-bias-corrected '^'Eu/'^^Eu isotope ratio 
Sample Peptide Concentration Peptide ratio. njfiy 
(^M) 
Measured" Theoretical 
I Bradykinin 0.6 1.000 0 .968± 
0.073 
2 Bradykinin 0.6 1.875 1.877± 
0.244 
3 Substance P 0.7 1.021 0 .969± 
0.116 
4 Bradykinin 0.6 1.029 1.029± 
0.206 
Substance P 0.7 1.027 1.018± 
0.163 
" Uncertainties are combined standard uncertainties calculated by 
combining all of the standard uncertainties in the measurement 
^ Springer 
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Sm standard was added post-column via a low dead volume 
t-piece. The peptide ratio (njny) was subsequently calcu-
lated using Eq. 1. 
A LC-ICP-MS chromatogram showing the element-
selective detection of '*'Eu and ' " E U isotopes in the 
bradykinin and substance P, after derivatisation with 
cDTPA and chelation with natural and isotopically enriched 
EU, is shown in Fig. 3. A comparison of the theoretical and 
measured peptide ratios for bradykinin, substance P and a 
mixture of the two peptides is shown in Table 1. As can be 
seen, the measured peptide ratios agreed extremely well 
wiUi the theoretical ratios, with relative errors of between 0 
10 5.2%, so, in principle, small differences in peptide 
expression should be delectable. In this particular case, the 
standard uncertainties associated with the measurements 
were quite high; however, it should be noted that these were 
combined standard uncertainties calculated by combining 
all standard uncertainties in the measurement using the 
method of Kragien [15]. Based on our experience of using 
isotope dilution analysis for the speciation of methylmer-
cury [ 1 6 ] , it should be possible to reduce the standard 
uncertainty to less than 6 % relative. Additionally, the 
relative quantitation of substance P was hindered by the 
fact that this peptide forms disulfide bridges relatively 
easily, so it elutes as several peaks at - 1 7 min. 
Detection limit 
Two factors influence the lowest concentration of peptide 
which can be determined using this method: the efficiency 
of derivatisation; and the instrumental detection limit of 
the derivatised peptide. The lowest detectable concentra-
tion of derivatised bradykinin using LC-ICP-MS was 
1 0 nM; however, in practice 1 0 p.M bradykinin was the 
lowest concentration that could be derivatised in sim and 
detected using the current approach. For the method to be 
comparable to current ESI-MS methods for relative 
quantitation, an improvement to nM concentrations is 
required. This can be achieved by improving the deriva-
tisation reaction efficiency, an area that is currently being 
investigated. 
Conclusion 
Derivatisation and isotopic labelling with Eu has enabled 
ICP-MS to be used for the detection and relative quantita-
tion of bradykinin and substance P, which are not normally 
amenable to detection. This method has potential for the 
accurate relative and absolute quantitation of peptides using 
ICP-MS. A number of challenges still need to be overcome 
to make this a viable approach, and work is ongoing in our 
laboratory to improve the derivarisation reaction efficiency 
and remove excess reagents using solid-phase derivatisation. 
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